University of Alabama in Huntsville

LOUIS
Dissertations

UAH Electronic Theses and Dissertations

2015

Isolation and identification of bioactive compounds from
conradina canescens gray
Noura S. Dosoky

Follow this and additional works at: https://louis.uah.edu/uah-dissertations

Recommended Citation
Dosoky, Noura S., "Isolation and identification of bioactive compounds from conradina canescens gray"
(2015). Dissertations. 64.
https://louis.uah.edu/uah-dissertations/64

This Dissertation is brought to you for free and open access by the UAH Electronic Theses and Dissertations at
LOUIS. It has been accepted for inclusion in Dissertations by an authorized administrator of LOUIS.

ACKNOWLEDGEMENTS

I would like to express my sincere and deep gratitude to my advisors, Dr. William N.
Setzer and Dr. Debra M. Moriarity for allowing me to work on this project and for their
constant guidance and assistance in the development, execution, and review of this study.
I truly appreciate their patience and encouragement. I would like to thank Dr. Bernhard
Vogler for his assistance, suggestions and for training me on the GC/MS and NMR. I
would also like to thank Dr. Leland Cseke and Dr. Ifedayo Victor Ogungbe for their
valuable comments and suggestions regarding this work.
I want to acknowledge all the programs which supported my work over these past four
years. First, I am grateful to the Ministry of Higher Education, Egypt, for funding my
salary, tuition, and travel for four years. I am also grateful to the Department of
Biological Sciences, University of Alabama at Huntsville for providing me with this
educational opportunity.
My gratitude extends to the members of Natural Product and Drug Discovery group. I
would love to thank all my friends and colleagues, especially Marcie Campbell and
Prabodh Satyal for their continuous support. I would like to thank the faculty and staff of
the University of Alabama in Huntsville, especially LaShun Lanier. Special thanks are
offered to William J. Guthrie for identification and collection of the plant.

v

I would like to offer my most sincere gratitude to my family for their overwhelming love,
support, and prayers. I especially want to thank my Mother for her encouragement to
pursue this degree and my loving husband, Muhammad S. Khan, for his continuous
support, help and understanding.
Finally, and above all, I thank Allah for everything. Without His generosity, I would have
been unable to complete this project. I have been blessed with so much by so many, and I
am forever grateful.

vi

TABLE OF CONTENTS
Page
List of figures ……………………………………………………………... x

1

List of tables ………………………………………………………………

xiv

List of Abbreviations ………………….…………………………………..

xv

Introduction

1

1.1 Natural products as drugs ……………………………………………..

1

1.2 Essential oils …………………………………………………………..

3

1.3 Terpenes ………………………………………………………………. 6

2

1.4 Infectious diseases …………………………………………………….

7

1.5 Cancer …………………………………………………………………

11

1.6 Leishmaniasis …………………………………………………………

21

1.7 Conradina canescens ……………………………………..…………..

26

1.8 Hyopthesis …………………………………………………………….

29

Experimental

30

2.1 Study area and plant material …………………………………………

30

2.2 Essential oil isolation …………………………………………………. 31
2.3 Gas chromatographic-Mass spectral (GC-MS) analysis ……………...

31

2.4 Phytoextraction …………………….………..………………………..

32

2.5 Chromatographic separation ………………………………………….. 33
2.6 Structure determination ……………………………………………….

35

2.7 Antimicrobial screening ………………………………………………

37

2.8 Cell culture and cytotoxicity screening ……………………………….

38

vii

2.8.1 Cell culture ……………………………………………………..

38

2.8.2 Subculture ………………………………………………………

40

2.8.3 Thiozolyl blue tetrazolium bromide (MTT) assay ……………..

41

2.9 Brine shrimp lethality assay ………………………………………….

44

2.10 Antileishmanial activity ….………………………………………….. 45
2.10.1 Parasite cultures ……………………………………………… 45
2.10.2 Antipromastigote assay ………………………………………. 46
2.10.3 Host cytotoxicity assay ………………………………………. 46

3

2.10.4 Selectivity index ……………………………………………...

47

2.10.5 Antimastigote assay …………………………………………..

47

2.11 Allelopathic activity …………………………………………………

48

Results and Discussion

50

3.1 Essential oil composition ……………………………………………... 50
3.2 The crude extract ……………………………………………………...

59

3.2.1 Characterization of compound (1) ………………………………

59

3.2.2 Characterization of compound (2) ………………………………

66

3.2.3 Characterization of compound (3) ………………………………

73

3.2.4 Characterization of compound (4) ………………………………

78

3.2.5 Characterization of compound (5) ………………………………

83

3.2.6 Characterization of compound (6) ………………………………

88

3.3 Antimicrobial activity ………………………………………………… 94
3.4 Cytotoxic activity ……………………………………………………..

95

3.5 Brine shrimp lethality …………………………………………………

97

viii

3.6 Antileishmanial activity ………………………………………………. 97
3.7 Allelopathic effects …………………………………………………… 99
4

Conclusions and Future work

103

4.1 Findings ……………………………………………………………….

103

4.2 Future work …………………………………………………………… 104
5

References

107

ix

LIST OF FIGURES
Figure

Page

1.1

Structures of common antimicrobial plant chemicals …………………....

11

1.2

Some examples of plant-derived anticancer drugs ………………………

18

1.3

(A) MCF-7 human breast cancer cell line, (B) MDA-MB-231 human
breast cancer cell line, and (C) 5637 human urinary bladder cancer cell
line ………………………………………………………………………..

20

1.4

Reduction of MTT and formation of formazan ………………………….

21

1.5

Life cycle of Leishmania spp. ……………………………………………

22

1.6

Forms of leishmaniasis. (A) cutaneous leishmaniasis, (B) diffuse
cutaneous leishmaniasis, (C) mucocutaneous leishmaniasis, and (D)
visceral leishmaniasis. ……………………………………………………

23

1.7

Current treatment of leishmaniasis ………………………………………

25

1.8

(A) Conradina canescens Gray, (B) C. canescens in flowering stage, (C)
C. canescens leaves, and (D) C. canescens flower ………………………

28

1.9

Distribution map of C. canescens ……………………………………..…

29

2.1

Map of Santa Rosa County, City of Navarre, Florida, USA ……………..

30

2.2

Hydrodistillation using Likens-Nickerson apparatus …...………………..

31

2.3

Soxhlet extraction of the crude extracts ………………………………….

32

2.4

(a) Column chromatography (active column), (b) Chromatographic
separation of C. canescens chloroform extract, (c) TLC plate under UV

2.5

light ……………………………………………………………………....

33

Vial-in-vial solvent diffusion method for recrystallization …………...…

34

x

Figure
2.6

Page
(A) Separation of SF2, (B) Separation of SF6, (C) Separation of SF7,
(D) Separation of SF2 using Preparative TLC, and (E) small silica gel
column …………………………….……………………….…………….

2.7

(a) Perkin-Elmer FT-IR Spectrometer and (b) Varian 500 MHz NMR
Spectrometer ……………………………………………………………….

2.8

36

Example of minimum inhibitory concentration (MIC) determination
using microbroth dilution assay ………………………………………….

2.9

36

38

(a) Summary of MTT assay, (b) Molecular Devices SpectraMax Plus
384 Microplate reader, and (c) Example of MTT plate ………………….

43

2.10 Summary of brine shrimp lethality assay ………………………………..

45

3.1

C. canescens essential oil ………………………………………………...

51

3.2

Chemical structures of major components of C. canescens oil ………….

51

3.3

Proton spectrum of compound (1) ……………………………………….

63

3.4

Carbon spectrum of compound (1) ………………………………………

63

3.5

HSQC spectrum of compound (1) ……………………………………….

64

3.6

HMBC spectrum of compound (1) ………………………………………

64

3.7

COSY spectrum of compound (1) ……………………………………….

65

3.8

Key HMBC and COSY correlations of compound (1) …………………..

65

3.9

IR spectrum of compound (1) ……………………………………………

66

3.10 Chemical structure of ursolic acid ……………………………………….

66

3.11 Proton spectrum of compound (2) ……………………………………….

70

3.12 Carbon spectrum of compound (2) ………………………………………

70

xi

Figure

Page

3.13 HSQC spectrum of compound (2) ……………………………………….

71

3.14 HMBC spectrum of compound (2) ………………………………………

71

3.15 Selected HMBC correlations of compound (2) ………………………….

72

3.16 COSY spectrum of compound (2) ……………………………………….

72

3.17 IR spectrum of compound (2) ……………………………………………

73

3.18 Chemical structure of betulin ………………………………….…………

73

3.19 Proton spectrum of compound (3) ……………………………………….

76

3.20 HSQC spectrum of compound (3) ……………………………………….

76

3.21 HMBC spectrum of compound (3) ………………………………………

77

3.22 COSY spectrum of compound (3) ……………………………………….

77

3.23 IR spectrum of compound (3) ……………………………………………

78

3.24 Chemical structure of β-amyrin ……………………………………….....

78

3.25 Proton spectrum of compound (4) ……………………………………….

80

3.26 Carbon spectrum of compound (4) ………………………………………

80

3.27 HSQC spectrum of compound (4) ……………………………………….

81

3.28 HMBC spectrum of compound (4) ………………………………………

81

3.29 COSY spectrum of compound (4) ……………………………………….

82

3.30 IR spectrum of compound (4) …………………………………………....

82

3.31 Chemical structure of myrtenic acid ……………………………………..

83

3.32 α-Pinene degradation and formation of myrtenic acid …………………...

83

3.33 Proton spectrum of compound (5) ……………………………………….

85

3.34 Carbon spectrum of compound (5) ……………………………………....

85

xii

Figure

Page

3.35 HSQC spectrum of compound (5) ……………………………………….

86

3.36 HMBC spectrum of compound (5) ………………………………………

86

3.37 COSY spectrum of compound (5) ……………………………………….

87

3.38 IR spectrum of compound (5) ………………………..…………………..

87

3.39 (a) GC-MS chromatogram of compound (5) and (b) compound library
search results……………………………………………………………...

88

3.40 Chemical structure of n-tetracosane ……………………………………...

88

3.41 Proton spectrum of compound (6) ……………………………………….

91

3.42 HSQC Spectrum of compound (6) ……………………………………….

92

3.43 HMBC spectrum of compound (6) ………………………………………

92

3.44 COSY spectrum of compound (6) ……………………………………….

93

3.45 IR spectrum of compound (6) ……………………………………………

93

3.46 Chemical structure of oleanolic acid ……………………………………..

94

xiii

LIST OF TABLES
Tables

Page

3.1

Chemical composition of Conradina canescens essential oils ………...

53

3.2

Antimicrobial activity of C. canescens essential oil …………………...

56

3.3

Allelopathic activity of C. canescens essential oil on lettuce (Lactuca
sativa) and perennial ryegrass (Lolium perenne) ……………………...

58

3.4

NMR assignment of Compound (1) (ursolic Acid) …………………...

62

3.5

NMR assignment of Compound (2) (betulin) ………………………….

69

3.6

NMR assignment of Compound (3) (β-amyrin) ……………………….

75

3.7

NMR assignment of compound (5) (n-Tetracosane) …………………..

84

3.8

NMR assignment of compound (6) (oleanolic Acid) ………………....

90

3.9

Antibacterial activity (as MIC in μg/mL) of C. canescens crude
extracts and isolated compounds ……………………………………...

3.10

95

Antifungal activity (as MIC in μg/mL) of C. canescens crude extracts
and isolated compounds ………………………………………………..

95

3.11

Cytotoxic effect (%Kill) of C. canescens crude extracts ……………....

96

3.12

Cytotoxic effect (IC50) of compounds isolated from C. canescens…....

96

3.13

Antileishmanial activity of C. canescens extracts ……………………..

97

3.14

Brine shrimp lethality of C. canescens extract and isolated compounds

98

3.15

Allelopathic activity of isolated compounds on lettuce (Lactuca

3.16

sativa) and perennial ryegrass (Lolium perenne) ……………………...

101

IC50 values for the allelopathic activity of isolated compounds ……….

102

xiv

LIST OF ABBREVIATIONS

AIDS

Acquired Immune Deficiency Syndrome

ATCC

American Type Culture Collection

ATP

Adenosine Triphosphate

CAMHB

Cation-Adjusted Mueller Hinton broth

CC50

Median Cytotoxic Concentration

CDC

Centers of Disease Control and Prevention

CDCl3

Deuterated Chloroform

CFU

Colony Forming Units

cm

Centimeter(s)

CO2

Carbon Dioxide

COSY

Correlation Spectroscopy

DMSO

Dimethyl sulfoxide

DNA

Deoxyribonucleic acid

EGF

Epidermal Growth Factor

EtOAc

Ethyl Acetate

FBS

Fetal Bovine Serum

GC-MS

Gas Chromatography – Mass Spectroscopy

G-CSF

Granulocyte Colony Stimulating-Factor

GI

Gastrointestinal

GM-CSF

Granulocyte-Macrophage Colony-Stimulating Factor

GTP

Guanosin-5′-triphosphate

xv

Hanks BSS

Hanks Balanced Saline Solution

HEPES

4-(2-Hydroxyethyl)piperazine-1-ethanesulfonic acid

HFBS

Heat-Inactivated Fetal Bovine Serum

HIV

Human Immunodeficiency Virus

HMBC

Heteronuclear Multiple Bond Correlation

HSQC

Heteronuclear Single Quantum Coherence

IC50

Median Inhibitory Concentration

FT-IR

Fourier Transform Infrared Spectroscopy

MCF-7

Michigan Cancer Foundation-7

mg

Milligram(s)

MHz

Megahertz

μg

microgram(s)

μL

microliter(s)

μm

micrometer(s)

MIC

Minimum Inhibitory Concentration

mL

Milliliter(s)

mM

Millimolar

MTT

3-(4,5-Dimethylthiazol-2-Yl)-2,5-Diphenyltetrazolium

NaHCO3

Sodium Bicarbonate

nm

Nanometer(s)

NMR

Nuclear Magnetic Resonance

PBS

Phosphate Buffered Saline

Pen-strep

Penicillin-Streptomycin

xvi

PKDL

Post Kala-azar Dermal Leishmaniasis

ppm

Parts Per Million

Rf

Retention factor

RI

Retention Index

RPMI

Roswell Park Memorial Institute

SCF

Stem Cell Factor

SD

Standard deviation

SF

Superfraction

SI

Selectivity Index

TGFα

Transforming Growth Factor Alpha

TLC

Thin Layer Chromatography

USDA

United States Department of Agriculture

USFWS

United States Fish and Wildlife Service

UTI

Urinary Tract Infection

UV

Ultraviolet

WHO

World Health Organization

xvii

CHAPTER ONE

Introduction
1.1 Natural products as drugs
Natural products, in general, are secondary metabolites. They are not directly essential
for the normal growth, development or reproduction of the organism producing them.
However, they are essential for the survival of some organisms as they attract pollinators
or protect against predators or competitors (Mann, 1999). They can be grouped as
essential oils, organic acids, terpenoids, glycosides, saponins, tannins, alkaloids, phenolic
compounds, steroids, resins, and others (Krishnaiah et al., 2009). These secondary
constituents may be specific to families, subfamilies, and genera and sometimes to certain
species. Throughout history, natural products have been the source of numerous active
ingredients in medicines: more than 80% of drugs were either based on natural products
or inspired by a natural compound (McChesney et al., 2007). The main sources of natural
products are higher plants, microbes, and marine animals. Higher plants have attracted
healers in ancient civilizations and researchers in recent times. They continue to be a rich
source for new compounds that have a wide variety of clinical activities (Brielman et al.,
2006). Many currently successful drugs are either based directly on a natural product or
derived from natural products (McChesney et al., 2007). More than 60% and 75% of total
drugs used in treatment of cancer and infectious diseases, respectively, have natural
1

origin (Zhang and Demain, 2005). It is a high possibility that there are many more drugs
yet to be discovered from the unstudied plants (McChesney et al., 2007).
The use of natural products as medicines started thousands of years ago through natural
poisons and traditional medicines. The earliest records date back to about 2600 BC and
were written on clay tablets. The Ebers papyrus is the best-known Egyptian
pharmaceutical record, dating to 1500 BC. It describes around 700 drugs (mostly from
plants) including formulas for gargles, snuffs, poultices, infusions, pills and ointments
(Cragg and Newman, 2005a). Documentation of the Chinese Materia Medica and the
Indian Ayurvedic systems date back to 1100 BC and 1000 BC, respectively (Cragg and
Newman, 2005a). After clinical, pharmacological, and chemical studies, these traditional
medicines formed the basis of most of the early medicines (Butler, 2004). Some of the
well-known examples are aspirin (an acetyl derivative of salicylic acid, which comes
from the bark of the willow tree, Salix alba), quinine (antimalarial drug isolated from the
bark of Cinchona sp.), and morphine (a powerful pain killer from Papaver somniferum)
(Butler, 2004). For many diseases, the current chemotherapy relies upon a limited
number of drugs that are essentially toxic and expensive. Therefore, natural products
represent good sources to search for new effective alternatives.
Despite the success of natural products as a chemical resource for drug leads, the drug
discovery industry has deemphasized natural products-based drug discovery during the
last two decades. The major pharmaceutical companies have lost interest in drug
discovery from natural products in favor of high-throughput synthetic compound library
screening and combinatorial synthesis. However, natural products are still being
developed into drugs. Recent technological breakthroughs such as microscale analytical
2

techniques for structure determination, structure-activity relationship studies, megagenomic approaches, and novel approaches for natural product cellular target
identification including genome wide target-based screening platforms, are all rapidly
leading to a renaissance of natural products chemistry. In fact, natural products, their
derivatives and synthetic compounds with a natural product core make up 38% of the
small molecule pharmaceuticals in use and 52% of all available anticancer drugs
(Newman et al., 2003).

1.2 Essential oils
Aromatic plants produce essential oils as secondary metabolites. Essential oils are
concentrated volatile compounds responsible for a plant’s characteristic odor. They
normally have a pleasant, perfumed smell and are composed primarily of terpenes,
terpenoid compounds, phenol-derived aromatic components and aliphatic components
(Bakkali et al., 2008). They can be found in all plant organs but are generally stored in
the secretory parts and glandular trichomes.
In nature, essential oils play an important role in the plant-environment interactions
including protection of plants against pathogens and herbivores (Nazzaro et al., 2013),
attraction of pollinators or dispensers while keeping away the undesired insects, and
allelopathy (Bakkali et al., 2008). For thousands of years, mankind has found numerous
uses for plant essential oils. Ancient civilizations, the Chinese, Indians, Egyptians,
Greeks, and Romans, used them in cosmetics, perfumes, and drugs as well as for
spiritual, therapeutic, hygienic, and ritualistic purposes (Fischer-Rizzi, 1990). Essential
oils possess many pharmacological properties, including antimicrobial, antioxidant,
3

analgesic, and anticarcinogenic activities (Bakkali et al., 2008). They were one of the
first preservatives, due to their antimicrobial properties. Ancient Egyptians used oils of
myrrh, sandalwood, attar of roses, and cedar in mummification as effective antibacterial
agents, which are partly responsible for the remarkable preservation of the mummies
(Baser and Buchbauer, 2010). Currently, essential oils are of great economic importance
in the perfume, cosmetics, soaps, food (as flavoring additives), sanitary, and drug
industries. The antibacterial and insecticidal properties of essential oils have also been
utilized in the agricultural industry to prevent plant diseases (Bakkali et al., 2008).
Moreover, essential oils are widely used in aromatherapy due to their anxiolytic and
relaxant effects, to relieve anxiety and depression and calm fears. Some well-known
examples include rose (Rosa damascena), lavender (Lavandula angustifolia), orange
(Citrus sinensis), and lemon (Citrus limon) (Fischer-Rizzi, 1990).
Due to the volatile nature of essential oils, special extraction methods are necessary to
separate them from the plant material (Worwood, 2001). The most common method of
extraction is steam or hydro-distillation in which the plant material is cooked with water
to release its oil as a steam or vapor, which is then condensed back into liquid form on
cooling. Distillation is a cost-effective method for essential oils production. The major
concern about using distillation is the possibility of thermal degradation of some of the
volatile components (Worwood, 2001).

4

Other extraction methods include the following:


Expression, which involves using high mechanical pressure to squeeze out the oils
without using heat. It is the method of choice for some nut and seed oils
(Worwood, 2001).



Solvent extraction, which involves the use of chemicals such as alcohol to soak
the plant material, especially flower petals, allowing them to release their volatile
oils. The outcome depends on the solvent used for soaking. Solvent extraction is
suitable for plant materials that have very low yields of essential oils or materials
that consist of mostly resinous components (Baser and Buchbauer, 2010).



Enfleurage, in which flower petals are placed on a layer of glass covered with
a thin layer of fat to extract the oil by diffusing into the fat layer. The fat layer is
then collected and the oil is extracted using alcohol. It is one of the oldest timeconsuming methods of extracting essential oils and is rarely used nowadays
because of its high cost (Worwood, 2001).



Carbon dioxide extraction, which involves using extraction equipment to
pressurize and liquefy CO2 that is then used to steam-distil the essential oils
(Worwood, 2001).

The extracted essential oils are usually mixtures of about 20- 60 compounds that vary
significantly in concentration. The major components of any essential oil are the
compounds present in high concentrations (20-70%), while minor components are
present in trace amounts, usually less than 0.05%. The biological properties of an
essential oil depend on its major components and their concentrations (Bakkali et al.,
5

2008). Thymol and its isomer, carvacrol, are the major constituents of Thymus
vulgaris essential oil (Nickavar et al., 2005) and are responsible for the strong
antimicrobial,

antioxidative,

antitussive,

expectorant,

anti-inflammatory

and

antispasmodic effects of the oil (Fachini-Queiroz et al., 2012). The oil of Eugenia
caryophyllata contains eugenol, which inhibits the proliferation of cancerous cells, and
geraniol which induces membrane depolarization and interferes with signaling pathways
and therefore inhibits colon cancer cell proliferation (Yoo et al., 2005).

1.3 Terpenes
Terpenes are the largest, most structurally diverse and most ubiquitous class of natural
products found especially in plants. They are hydrocarbon–based natural products that are
all derived from common isoprene units. They consist of two or more isoprene (C5H8) or
isopentane (C5H10) units. The biosynthesis of terpenoids occurs through the mevalonic
acid pathway. Three acetyl coenzyme-A (Acetyl Co-A) molecules combine to yield one
five-carbon isopentane unit. Further additions of these isopentanoid units lead to the
formation of geranyl pyrophosphate, the precursor of monoterpenes (C10). C5 elongations
of geranyl pyrophosphate, catalyzed by prenyl transferase, give rise to farnesyl
pyrophosphate and geranylgeranyl pyrophosphate, which then form the sesquiterpenes
and the diterpenes, respectively. This assembly of terpenoids, which commonly involves
cyclizations and modifications with various functional groups such as hydroxyl groups,
and carbonyl groups, generates the many thousands of terpenoid compounds present in
plant tissues. All plants synthesize some terpenoids, including photosynthetic pigments
and plant steroids, to fulfill their basic needs. Many plants additionally produce resins,
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which are di- and triterpenoids thought to protect the leaf surface in arid environments, or
essential oils. Pentacyclic triterpenes are known for a wide-range of biological and
pharmaceutical activities including antiviral, antimicrobial, anti-inflammatory, cytotoxic
and cardiovascular effects (Laszczyk, 2009).
1.4 Infectious diseases
Infectious diseases are disorders caused by pathogenic organisms such as viruses,
bacteria, fungi or parasites. Many microorganisms live in and on our bodies as the normal
microbial flora. This normal flora influences the anatomy, physiology, susceptibility to
pathogens, and morbidity of their host. They are normally harmless and sometimes even
helpful, but under certain conditions, some organisms may act as opportunistic pathogens
and cause disease (Vynnycky and White, 2010). Infectious diseases can be passed by
direct contact from one person to another or can be transmitted via infected insects or
animals. Ingesting contaminated food or water or being exposed to pathogenic organisms
in the environment can also cause disease. Each infectious disease has its own symptoms
according to the pathogen but there are some common symptoms such as diarrhea,
unexplained fever, muscle ache and fatigue. Mild infections often respond to home
remedies and rest while the life-threatening infections require hospitalization and
treatment. Many infectious diseases can be prevented by vaccines while others are still
under investigation to find new means to treat or protect against these microorganisms.
Moreover, pathogenic microorganisms are becoming more and more resistant to
conventional chemicals and drugs. Drug resistance is a serious and evident worldwide
problem that leads to prolonged treatment time of infected patients, increased costs, and
increased mortality, and therefore has increased the demand for identifying new biocides
7

with broad activity (Abad et al., 2007). Structures of some common antimicrobial plant
compounds are shown in Figure (1.1).
Viral infections are one of the major causes of human disability and mortality around the
world (Flint et al., 1999). Viruses are characterized by their high diversity and rapid
mutation. They cause a multitude of diseases, ranging from the common cold to AIDS.
Recently, people around the world were watching with fear the Ebola virus outbreak that
spread from Sudan to three African countries, Guinea, Liberia and Sierra leone then
appeared in the United States (Kingdom, 2015). Few antiviral compounds have been
formally approved for clinical use such as amantadine and rimantadine to treat influenza
A virus; zidovudine, didanosine, zalcitabine and stavudine to treat human
immunodeficiency virus (HIV); and ribavirin for treating respiratory syncytial virus (De
Clercq, 1996). They specifically inhibit one or more steps of virus replication such as
viral adsorption, penetration, uncoating, viral nucleic acid synthesis and viral protein
synthesis. The use of these antiviral drugs is limited by some factors including toxic side
effects, narrow antiviral spectrum, development of drug-resistant mutants and
ineffectiveness against the latent virus (De Clercq, 1996). In order to overcome these
limitations, the search for more effective compounds is continuing.
Bacteria are unicellular prokaryotic microorganisms, typically a few micrometers in
length. They have a number of shapes, ranging from spheres to rods and spirals. Bacteria
can survive in a wide range of environments, including soil, water, extreme heat and cold,
acidic hot springs, radioactive waste, and the human body. They live either free or
in symbiotic and parasitic relationships with other organisms (Vynnycky and White,
2010). Most bacteria are harmless, or even beneficial as some bacteria help by digesting
8

food, destroying disease-causing microbes, and providing essential nutrients. However,
some bacteria can cause mild, moderate and severe diseases to human (Rubin et al.,
2012). Pathogenic bacteria are responsible for many serious infectious diseases such as
tetanus, typhoid fever, diphtheria, syphilis, and leprosy. Escherichia coli, a well-known
Gram-negative bacterium, is normally found in the gut and urinary tract. However, E.
coli is among the most frequent opportunistic human pathogens causing more than 90%
of urinary tract infections (UTIs) and several diarrheal cases around the world (Rubin et
al., 2012). It can also cause meningitis and sepsis in newborns. Bacillus cereus is a rodshaped, Gram-positive bacterium, well known as a cause of two food poisoning
syndromes: emetic syndrome (rapid onset syndrome characterized by nausea and
vomiting),

and

diarrheal

syndrome

(slower

onset)

(Turnbull,

1996).

Streptococcus and Pseudomonas are responsible for pneumonia.
Fungal infections are caused by pathogenic or opportunistic fungi. The incidence of
fungal infections increases among immunocompromised people such as those with
human immunodeficiency virus (HIV), acquired immune deficiency syndrome (AIDS),
and recipients of organ transplant (Bruatto et al., 1991). Many skin diseases, such as
ringworm and athlete's foot, are caused by fungi. Some types of fungi can infect the lungs
or nervous system. According to Centers of Disease Control and Prevention (CDC,
2015), the genus Candida, especially C. albicans, is the most common opportunistic
human pathogen. It is normally found in small amounts in the human body but when it
overgrows, it can cause candidiasis.

Candidiasis can occur in the mouth or throat

(referred to as oropharyngeal candidiasis/thrush), genitals (known as yeast infection),
skin of a baby bottom (known as diaper rash), or blood (known as invasive candidiasis or
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candidemia). Even Saccharomyces cerevisiae, the common baking yeast, can cause
Fungemia to humans, especially immunosuppressed or critically ill patients (Muñoz et
al., 2005). Antifungal resistance with prolonged treatment has made it difficult to treat
fungal infections and created substantial interest in the search for new therapeutic
antifungal agents (Fan- Havard et al., 1991). Amphotericin-B is widely used in treating
fungal infections, in spite of its severe side-effects such as hepatic (Guillaume et al.,
1996) and kidney damages (Bennet, 1974). Several plant latex (Giordani et al., 1999) and
essential oils (d’Auria et al., 2001) have shown an antifungal effect. Giordani et al.
(2004) reported that combining Amphotericin-B with essential oil from Thymus vulgaris
as a second antifungal agent not only can decrease the necessary quantity of the drug and
therefore decrease or eliminate its toxic side-effects, but also can suppress the emergence
of mutants resistant to that drug.
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Figure (1.1). Structures of common antimicrobial plant chemicals.

1.5 Cancer
Cancer is one of the leading causes of death worldwide. It is the second most common
cause of death in the U.S. as it accounts for 1 of every 4 deaths (American Cancer
Society, 2015). In 2015, about 1.66 million individuals in the U.S. are expected to be
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diagnosed with cancer (not including noninvasive cancers) and approximately 1,620
individuals are expected to die per day (American Cancer Society, 2015). Cancer is a
class of diseases characterized by abnormal and uncontrolled cell division and growth
that may invade the surrounding tissues and result in malignant tumor formation (Chow,
2010). Cancer can result from certain internal factors (such as inherited genetic
mutations, hormones, and immune conditions), infectious organisms (such as
retroviruses), an unhealthy diet, obesity, and exposure to external factors (such as
tobacco, pollutants and radiation) (Anand et al., 2008). These factors may act together or
in sequence to cause cancer. Having a new lump, abnormal bleeding, a prolonged cough,
unexplained weight loss, and a sudden change in bowel movements are among the
common signs of cancer (American Cancer Society, 2015).
In normal cells, tumor suppressor genes regulate cell reproduction. Cancer can result
from a series of mutations that inactivate the tumor suppressor genes which in turn causes
cells to proliferate leading to further inactivation of DNA repair genes, to create
oncogenes that ultimately cause the cells to become cancerous (Cooper, 1992). Compared
to normal cells, cancer cells have a different metabolic profile represented in selfsufficiency in growth signals, insensitivity to growth-inhibitory signals, increased aerobic
glycolysis (Warburg effect), increased mitochondrial activity from glutamine catabolism
(glutaminolysis), increased lactate production, hyperpolarized mitochondrial membrane
increased production of reactive oxygen species, evasion of programmed cell death
(apoptosis), limitless replicative potential, sustained angiogenesis, and tissue invasion and
metastasis (Hanahan and Weinberg, 2000; Sun et al., 2011).
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There are more than a hundred types of cancer, with distinct tumor subtypes. These
cancers differ in their tissue of origin, original cell type, response to hormonal signals and
proliferation method (Hanahan and Weinberg, 2000). According to the tissues from
which cancer cells arise, there are four main groups: carcinomas (arising from epithelial
tissues), sarcomas (arising from transformed cells of mesenchymal origin like a muscle or
connective tissue), lymphomas (from B or T lymphocytes), and leukemias (from the
blood and bone marrow). Carcinomas are the most common form of cancer.
The most common form of cancer among women around the world is breast cancer.
Breast cancer ranks as the fifth cause of death from cancer overall (Gangopadhyay et al.,
2013). It is the most frequently diagnosed cancer in American women. It accounts for
29% of new cancer cases and 26% of deaths among women in the U.S. during 2015
(American Cancer Society, 2015). The disease occurs almost entirely in women, but men
can get it too. Breast cancers are often a type of carcinoma called adenocarcinoma which
starts in glandular tissue. Breast cancer can be classified based on proteins on or in the
cancer cells, into groups like hormone receptor-positive or triple-negative. It can also be
classified based on the origin of the cancer cells into:
 Ductal carcinoma: It is the most common type of breast cancer and begins in the
cells that line the milk ducts. It includes two subtypes: ductal carcinoma in situ in
which the cancer cells are only in the lining of the milk ducts, and have not
spread to other tissues in the breast), and invasive ductal carcinoma in which the
cancer cells break through the ducts and spread into other parts of the breast
tissue or the body.
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 Lobular carcinoma: In which the cancer cells begin in the lobes/Lobules of the
breast. It includes two subtypes: lobular carcinoma in situ and invasive lobular
carcinoma.
Urinary bladder cancer is more common among Caucasian men than women, almost four
times higher in men. It accounts for 7% of new cancer cases and 4% of deaths among
men in the U.S. during 2015. Smoking is the most well-established risk factor for
bladder cancer. The most common symptom of bladder cancer is bleeding in the urine
(hematuria) (American Cancer Society, 2015).
Several methods are currently used to treat cancer including surgery, radiation,
chemotherapy, hormone therapy, biological therapy, and targeted therapy (American
Cancer Society, 2015). These treatments can be used individually or in combination in
order to stop the tumor growth or cure cancer. Chemotherapy is the most commonly used,
and often the most effective, method for treating metastasized cancers. If possible, solid
tumors are often removed by surgery or irradiation and chemotherapeutic drugs can then
be used as adjuvants. Chemotherapy is usually given in repeated cycles of treatment. It
involves the distribution of highly toxic drugs orally, intravenously or intrathecally.
Chemotherapeutic drugs are usually used in combination to give a more effective result.
For hematological cancer types such as leukemia, chemotherapy with combinations of
cytotoxic drugs is used as first-line treatment. These drugs target the cells which rapidly
divide (including normal cells such as bone marrow, digestive tract and hair follicles) and
are unable to differentiate between normal and cancer cells. They often lead to unpleasant
side effects such as hair loss, loss of appetite, anaemia, persistent itching, and fatigue
(National Cancer Institute, 2015), and merely extend the patient’s lifespan by a few years.
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Chemotherapeutic agents can be classified into: alkylating agents (which attack G bases),
taxanes (microtubule disruptors), topoisomerase I and II inhibitors, platinum complexes
(crosslink DNA), anthracyclines (intercalating), antimetabolites (purine and pyrimidine
antagonists), and tubulin stabilizers/destabilizers. Despite the fact that the undesirable
effects subside once the drug is removed, they increase the demand for new
chemotherapeutic agents with greater specificity or different mechanisms of action (Kufe
et al., 2003).
Higher plants provide a natural reservoir of valuable anticancer agents with novel
structures and unique mechanisms of action (Cragg et al., 2009). The active
phytochemicals can also act as lead structures for chemical modifications that enhance
their activity. Several plant products have been cited for their possible anti-tumor actions
on many types of cancers. Some examples of plant-derived anticancer natural products
(Figure 1.2) include:


The vinca-alkaloids, vinblastine and vincristine were isolated from the
Madagascar periwinkle Catharanthus roseus (Apocynaceae). They were the first
agents to advance into clinical use for cancer treatment (Cragg and Newman,
2005b).



Paclitaxel (Taxol®), a diterpenoid, was isolated from the bark of the Pacific Yew,
Taxus brevifolia (Cragg and Newman, 2005b) as an antimicrotubule agent. It’s an
approved anticancer chemotherapy drug used for the treatment of breast, ovarian,
lung, bladder, prostate, melanoma, esophageal, as well as other types of solid
tumor cancers.
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Etoposide – a semisynthetic antineoplastic agent derived from podophyllotoxin
(isolated from the Mayapple, Podophyllum peltatum) (Damayanthi and Lown,
1998).



Combretastatin A-4 phosphate was isolated, while screening for anticancer
activity, from the South African plant Combretum caffrum (Pettit et al., 1989). It
inhibits tubulin polymerization (Pettit et al., 1989; Butler, 2005).



Phenoxodiol, a derivative of the isoflavone daidzein, was isolated from Soja
hispida (Walz, 1931; Butler, 2005). It acts by inhibiting NADH oxidase activity
(Butler, 2005).



®

The alkaloid, homoharringtonine (Ceflatonin ), was isolated from Cephalotaxus
harringtonia while screening for anticancer activity (Powell et al., 1972). It
inhibits protein synthesis (Butler, 2005).



Ingenyl 3-angelate, a diterpene ester, was isolated from Euphorbia peplus based
on the plant’s use as a home remedy for skin cancer (Ogbourne et al., 2004). It is
a protein kinase C activator (Butler, 2005).



Isodiospyrin was isolated from the root of Diospyros morrisiana (Ebenaceae) as
an inhibitor of human topoisomerase I, and a potential anticancer agent. Its
structure is similar to diospyrin which is a known DNA topoisomerase poison.
Isodiospyrin was reported to have cytotoxic activity against colon tumors,
leukemia, and HeLa cervical carcinoma (Ting et al., 2003).
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Jatrophane 1 was isolated from Euphorbia semiperfoliata, as an antimitotic agent
that interacts with tubulin in a mechanism similar to that of Taxol (Cragg and
Newman, 2005b).



Tingenone, a quinone methide triterpene, was isolated from the bark of Salacia
petenensis (Setzer, 2001). It binds to DNA in a non-intercalative fashion. Morita
et al. (2008) reported the antimitotic activity of tingenone.



Chelerythrine, a quaternary benzophenanthridine alkaloid, was found in
Chelidonium majus. It is a potent and selective protein kinase C inhibitor (Herbert
et al., 1990) and a known DNA-intercalator (Bai et al., 2006).



Thymoquinone is the major constituent of the essential oil of Nigella sativa seeds.
It has been reported to have hepatoprotective, anti-oxidative, anti-inflammatory
and anti-tumorigenic activities. It acts as an anticancer agent through inducing
p53- independent apoptosis (Khader and Eckl, 2014).



Ellipticine is a plant alkaloid with strong antitumor activity. It was first isolated
from Ochrosia elliptica (Kansal and Potier, 1986). It is known for being a DNAintercalating inhibitor of topoisomerase II.

In a tumor, the majority of cells do not have the ability to survive indefinitely, but there
are some cells that can grow continuously and cause increased growth of the tumor.
These immortal cells can be isolated and grown in culture for study for an indefinite
period of time (Freshney, 2010). The term cell line refers to a population of
cells developed from a homogeneous tissue source that can be grown in a suitable
nutrient culture medium under controlled conditions, outside their natural environment.
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Figure (1.2). Some examples of plant-derived anticancer drugs.
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Therefore, a cell line is thought to consist of cells with a uniform genetic makeup. In this
study, three cell lines were used to test for cytotoxicity, namely MCF-7, MDA-MB-231
and 5637.
MCF-7 (Figure 1.3a) is a human breast cancer cell line derived as a pleural effusion from
human mammary gland adenocarcinoma and has been used extensively in research.
MCF-7 stands for Michigan Cancer Foundation-7 (now known as Barbara Ann
Karmanos Cancer Institute), the institute where the cell line was established in 1973
(Soule et al., 1973). The cell line was isolated from a 69-year-old Caucasian woman.
MCF-7 cell line is very useful for in vitro breast cancer studies because it has retained
several ideal characteristics particular to the mammary epithelium. Cells are epitheliallike in morphology, adherent, estrogen-receptor positive and can live more than a few
months. In vitro, MCF-7 cells grow in monolayers with a doubling time of 29h. They can
be grown in RPMI 1640 supplemented with 10% fetal bovine serum (FBS), 30mM
HEPES, sodium bicarbonate, and Penicillin-Streptomycin at pH =7.35 (Freshney, 2005).
MDA-MB-231 (Figure 1.3b) is a human breast cancer cell line isolated from pleural
effusions of a Caucasian breast cancer patient in 1973 at M. D. Anderson Cancer Center.
The cell line was obtained from a 51-year-old Caucasian woman. In vitro, cells are
epithelial-like in morphology, spindle-shaped, adherent, estrogen-receptor negative and
exhibit invasive properties. MDA-MB-231 cell line is widely used as a model for
estrogen-receptor negative breast cancer with applications in the study of tumorigenicity,
metastasis, and cell invasion. The cells express the WNT7B oncogene (Huguet et al.,
1994), epidermal growth factor (EGF) receptor, and transforming growth factor alpha
(TGF alpha) (Bates et al., 1990). Normal chromosomes N8 and N15 were absent from
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the karyotype of this cell line (Satya-Prakash et al., 1981). MDA-MB-231 Cells have a
doubling time of 38h and can be grown in RPMI 1640 supplemented with 10% fetal
bovine serum (FBS), 30mM HEPES, sodium bicarbonate, and Penicillin-Streptomycin at
pH =7.35 (Freshney, 2005).
5637 (Figure 1.3c) is a human urinary bladder cancer cell line obtained from the primary
bladder carcinoma of a 68-year-old Caucasian man. Cells are epithelial-like and adherent
with a doubling time of 24h. 5637 is known to produce and secrete large quantities of
various growth factors including granulocyte colony stimulating-factor (G-CSF),
granulocyte-macrophage colony-stimulating factor (GM-CSF), stem cell factor (SCF)
and others. They can be grown in RPMI 1640 supplemented with 10% FBS, 1mM
sodium pyruvate, 2.5 g/L glucose, 30mM HEPES, NaHCO3, and Penicillin-Streptomycin
at pH =7.35 (Langdon, 2004).
(A)

(B)

(C)

Figure (1.3). (A) MCF-7 human breast cancer cell line, (B) MDA-MB-231 human breast cancer
cell line, and (C) 5637 human urinary bladder cancer cell line.

MTT (3-(4,5-Dimethylthiazol-2yl)-2,5-diphenyltetrazolium bromide) assay is an
important tool in measuring the cytotoxic effects of certain compounds/extracts on the
cell line’s viability (Freshney, 2005). The number of surviving cells is determined
indirectly by MTT dye reduction. MTT is a yellow water-soluble tetrazolium dye that is
reduced by enzymes in live, but not dead, cells to a purple formazan product that is
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insoluble in aqueous solutions. Formazan crystals are formed over the course of four
hours after addition of MTT solution. The reaction is shown in Figure (1.4). The amount
of MTT-formazan produced is determined spectrophotometrically once the crystals have
been dissolved in a suitable solvent (e.g. DMSO) (Davis, 2011).

Figure (1.4). Reduction of MTT and formation of formazan.

1.6 Leishmaniasis
Leishmania (trypanosomatidae) is a genus of parasitic protozoa that causes leishmaniasis
to humans (Handman, 2001). Leishmaniasis (or leishmaniosis) is a worldwide distributed
group of diseases with a broad spectrum of clinical manifestations depending on the
causing species and the immunological status of the host (Monzote et al., 2011).
Leishmaniasis is one of the most neglected tropical diseases affecting largely the poorest
of the poor, mainly in developing countries (Bern et al., 2008). According to WHO,
about 310 million people are considered at risk of contracting leishmaniasis, and 1.3
million new cases occur worldwide yearly (World Health Organization, 2015). The
disease is transmitted to humans by the bites of infected female phlebotomine sandflies
(Phlebotomus sp. and Lutzomyia sp.). The parasite has a heteroxenous lifecycle (Figure
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1.5) alternating between intracellular amastigotes in the mammalian cells and flagellated
promastigotes in the vector (Barrera et al., 2013). In the mammalian host, Leishmania
survives and multiplies as intracellular non-motile amastigotes (about 2.3μm) in the
phagolysosomes of macrophages or other reticulo-endothelial cells and replicates in the
infected tissue leading to its damage. After being ingested by a sandfly, the parasite
multiplies in the gut as flagellated promastigotes (15-20 μm long), migrates to the
proboscis, and enters a new vertebrate host when the fly bites (Ogungbe et al., 2012).

Figure (1.5). Life cycle of Leishmania spp. (source: Centers for Disease Control and Prevention; CDC)

Leishmaniasis can be present in four main forms: cutaneous, diffuse cutaneous,
mucocutaneous and visceral (World Health Organization, 2015).

Cutaneous

leishmaniasis (Figure 1.6A) is caused by L. major and L. tropica in Asia, Europe and
Africa and L. mexicana in North and South America. It affects about 1-1.5 million people
22

mainly in Peru, Brazil, Syria, Saudi Arabia, Algeria, Iran, Pakistan, and Afghanistan
(Murray et al., 2005) and is characterized by the development of self-healing skin lesions
(Herwaldt, 1999). The infection by L. tropica is severe, chronic and difficult to treat
whereas the infection by L. mexicana is benign.

(A)

(B)

(C)

(D)

Figure (1.6). Forms of leishmaniasis. (A) Cutaneous leishmaniasis, (B) Diffuse cutaneous leishmaniasis,
(C) Mucocutaneous leishmaniasis, and (D) Visceral leishmaniasis. (source: Centers for
Disease Control and Prevention; CDC)

Diffuse cutaneous leishmaniasis (Figure 1.6B) is relatively rare, caused by L.
amazonensis and L. aethiopica, occurs due to defective cell mediated immune response
and is characterized by lesions around the face and arms which do not heal easily (Chan23

Bacab and Peña-Rodríguez, 2001). Mucocutaneous leishmaniasis (Figure 1.6C)is caused
mainly by L. braziliensis and L. panamensis and is characterized by extensive
disfiguration of nasal septum, lips, and palate and development of lesions and ulcers at
mucosal regions (nose, mouth, throat cavities) and adjacent tissues (World Health
Organization, 2015). Visceral leishmaniasis (Kala-Azar) (Figure 1.6D) is the most severe
and fatal form of leishmaniasis, affecting 0.5 million people (about 70,000 deaths/year) in
India, Bangladesh, Nepal, Sudan and Brazil (Murray et al., 2005). It is caused by L.
donovani, and is characterized by affecting the internal organs like liver, spleen and bone
marrow. The major symptoms are irregular fever, weight loss, enlargement of liver and
spleen, and anemia (World Health Organization, 2015). The incubation period varies
from weeks to months. A major risk associated with this form of the disease is the
development of Post Kala-azar Dermal Leishmaniasis (PKDL) that appears as macular,
papular or nodular rash usually on face, upper arms, trunks and other parts of the body
(World Health Organization, 2015).
Current chemotherapy for leishmaniasis still relies upon a limited number of drugs that
are toxic, expensive and relatively inefficient. It is mainly based on the systemic
administration of pentavalent antimonials like sodium stibugluconate and meglumine
antimonite (Salem and Werbovetz, 2006) or amphotericin B, with several adverse side
effects and emerging parasite resistance (Mishra et al., 2007) (Figure 1.7). By binding to
various enzymes associated with glycolysis and oxidation of fatty acids, pentavalent
antimonials reduce the net generation of ATP and GTP, and therefore inhibit energy
production in amastigotes (Berman, 1988). Amphotericin B, pentamidine, and oral
miltefosine have been approved for human visceral leishmaniasis. Amphotericin B
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increases the permeability of the parasite’s cell membrane by binding to ergosterol and
therefore leads to its death while pentamidine binds to the parasite’s DNA (Chan-Bacab
and Peña-Rodríguez, 2001, Ouellette et al., 2004). Pentavalent antimonials and
pentamidines are known to cause severe side effects including cardiotoxicity, hepatic and
renal insufficiency, stiff joints, and gastrointestinal distress whereas Amphotericin B
causes alteration of renal function (Herwaldt, 1999). Other major limitations of current
chemotherapy include the high cost and the need to administer the drugs as an injection
or infusion for a prolonged period of time. In addition, antimonials resistance has been
reported in northeast India (Croft and Yardley, 2002). Therefore, the current condition of
leishmaniasis calls for a serious search for new effective alternatives for treatment.
Several plant terpenes were reported to have antileishmanial activity including ursolic
acid and oleanolic acid (Salem and Werbovetz, 2006), dihydrobetulinic acid, linalool
(Sen and Chatterjee, 2011), espintanol, jatrogrossidione and jatrophone (Chan-Bacab and
Peña-Rodríguez, 2001), and racemoside A (Polonio and Efferth, 2008).

Figure (1.7). Current treatment of Leishmaniasis.
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1.7 Conradina canescens
Lamiaceae (Labiatae) is rich in herbs and medicinal plant species, which are of great
economic importance. Many species of Lamiaceae produce essential oils which are
secreted by glandular hairs on aerial vegetative organs and some reproductive organs.
Conradina is a small genus of just seven native US species characterized by dense hairs
on their lower leaf surfaces and by a sharply bent corolla tube in the flowers. Conradina
is a group of morphologically distinctive, narrow-leaved, aromatic shrubs. Each species
occupies a separate geographical region (Gray, 1965). Four of these species are on the
United States Fish and Wildlife Service’s (USFWS) federal list of endangered or
threatened plants (Conradina brevifolia, C. glabra, C. etonia, and C. verticillata). Despite
the fact that Conradina species are morphologically unique, there are two problems about
species status based on morphology. First, C. brevifolia (endangered species) shares a lot
of morphological characteristics with C. canescens (relatively widespread). Second,
populations of Conradina in Santa Rosa County, Florida, have morphological
characteristics in common with both C. glabra (endangered species) and C. canescens.
Conradina was subject to several phylogenetic analyses using four data partitions: plastid
DNA, internal transcribed spacer, and two members of the GapC gene family. Due to the
endangered status of four Conradina species, it was important to resolve the species
relationships, clarify species limits and elucidate the evolutionary processes in order to
help with conservation plans. Phylogenetic analyses of Conradina indicated that most
species are nonmonophyletic, i.e. they do not consist of an ancestral species and all its
descendants (Edwards et al., 2008).
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Conradina canescens Gray is a common small (up to 1 m in height; Figure 1.8A and B),
evergreen, compact shrub. Its narrow needle-like whorled leaves are recurved silvery
gray, and grow on numerous slender upright stems (Figure 1.8C) (Bell and Taylor, 1982).
The flowers and leaves have an herbal scent similar to those of Rosmarinus officinalis,
which gives Conradina its common name, false rosemary. The leaves release a strong
mint-like or terpenoid odor when crushed. Similar to rosemary, the fresh leaves of C.
canescens can be used as a seasoning in cooking. Typically, flowers are small
zygomorphic, white to pale lavender in color and appear near the tops of the plant in
early spring till fall (Figure 1.8D). Blooms covering the terminal branches release a minty
fragrance into the air. C. canescens is the most morphologically variable within this
genus (Peterson, 1998).
C. canescens originated from the Gulf Coast. Although this species is common in its
native range, it is endemic to only a small area of west Florida and adjacent Alabama and
southern parts of Mississippi (USDA Symbol: COCA19) (Figure 1.9) (Peterson, 1998).
It occurs on coastal dunes, in scrubs and in pineland ecosystems. It shows tolerance for
the heat and humidity of the Southeast and is considered a drought-tolerant landscape
plant that grows best in lean, sandy soils (Harrison, 2006). C. canescens is one of the
indicator species for wooded dunes (Looney and Gibson, 1995) and is an excellent
candidate for restoration of coastal areas. It can be used for beach projects that require
planting on the back side of primary dunes, or any side of secondary dunes. The plant
was easily propagated in the University of Florida, Institute of Food and Agricultural
Sciences Extension using softwood stem cuttings from terminal shoots. There are very
limited studies on the chemical composition of this plant species. These studies focused
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on identifying the compounds responsible for the strong allelopathic activity
demonstrated by this species. Water washes of C. canescens fresh leaves were reported to
have strong inhibitory effects on germination and growth of Schizachyrium scoparium
(Fischer et al., 1988; Williamson et al., 1989).

(A)

(B)

(C)

(D)

Figure (1.8). (A) Conradina canescens Gray, (B) C. canescens in flowering stage, (C) C. canescens leaves,
and (D) C. canescens flower.
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Figure (1.9). Distribution map of C. canescens. Δ represents C. canescens.
1.8. Hypothesis
According to the available literature, the chemical profile of this species has not been
studied yet or tested for bioactivity or cytotoxicity, except for allelopathy. Since C.
canescens is similar in appearance and odor to rosemary, our hypothesis was that C.
canescens could possess an economic and medicinal importance similar to that of
rosemary. There might be some bioactive compounds with cytotoxic, antileishmanial,
allelopathic or antimicrobial activities yet to be discovered. Hence, we decided to
perform the above mentioned assays.
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CHAPTER TWO

Experimental

2.1 Study area and plant material
The aerial parts of Conradina canescens were collected from private properties in Santa
Rosa County, near the city of Navarre, Florida, USA (Figure 2.1) in March and again in
May of 2010 and 2014. The plant was collected and identified by William J. Guthrie, a
chef in Florida. Each sample consisted of apical cuttings over 10 cm long. The samples
were mailed to UAH where plant materials were air-dried for several days at room
temperature.

Figure (2.1). Map of Santa Rosa County, City of Navarre, Florida, USA.
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2.2 Essential Oil Isolation
Approximately 25 g of each sample was crushed and hydrodistilled using a LikensNickerson apparatus (Figure 2.2) with continuous extraction with chloroform for 4 h to
give a clear yellow essential oil, which was stored at 4ºC until analysis.

Figure (2.2). Hydrodistillation using Likens-Nickerson apparatus.

2.3 Gas Chromatographic – Mass Spectral (GC-MS) Analysis
The essential oils of C. canescens were analyzed by GC-MS using an Agilent 6890 GC
with Agilent 5973 mass selective detector [MSD, operated in the EI mode (electron
energy = 70 eV), scan range = 40-400 amu, scan rate = 3.99 scans/sec], and an Agilent
ChemStation data system. The GC column was an HP-5ms fused silica capillary column
with a (5% phenyl)-polymethylsiloxane stationary phase, film thickness of 0.25 µm, a
length of 30 m and an internal diameter of 0.25 mm. The carrier gas was helium with a
column head pressure of 48.7 kPa and a flow rate of 1.0 mL/min. Inlet temperature was
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200°C and interface temperature was 280°C. The GC oven temperature program was as
follows: 40°C initial temperature, hold for 10 min; increased at 3°C/min to 200°C;
increased 2°C/min to 220°C. A 1% w/v solution of the sample in dichloromethane was
prepared and 1 µL was injected using a 10:1 split ratio (Monzote et al., 2011).
Identification of the oil components was based on their retention indices (RI) determined
by reference to a homologous series of n-alkanes, and by comparison of their mass
spectral fragmentation patterns with those reported in the literature (Adams, 2007).
2.4 Phytoextraction.
Extraction of the dried leaf powder (360 g) was performed using a Soxhlet apparatus
(Figure 2.3) with refluxing chloroform for 8 h, followed by another 8 h with refluxing
methanol to prepare extracts containing non-polar and polar components, respectively.
After evaporation to a constant weight, the yield was 84.45 g and 70 g of chloroform
extract and methanol extract, respectively.

Figure (2.3). Soxhlet extraction of the crude extracts.
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2.5 Chromatographic separation.
The crude chloroform extract of C. canescens leaves (25 g) was separated using flash column
chromatography (silica gel: 40-63 μm particle size and 60 Å porosity as the stationary phase;
glass column: 90 cm L  5 cm D) (Figure 2.4(a)). Hexane was used to pack the column. The
column was eluted with a step gradient of hexane/ethyl acetate (EtOAc) (90% hexane, 4 L;
80% hexane, 4 L; 50% hexane, 3 L; 20% hexane, 3 L; 100% EtOAc, 2 L), then washed by
ethanol as illustrated in Figure (2.4(b)).

(b)

(a)

(c)

Figure (2.4). (a) Column chromatography (active column), (b) Chromatographic separation of C.
canescens chloroform extract, (c) TLC plate under UV light.

The collected fractions were evaluated by thin-layer chromatography (TLC). A few drops of
concentrated fractions were spotted on TLC plates (200 μm thickness). The TLC plates were
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developed in the appropriate solvent system and viewed under UV light (Figure 2.4(c)).
Fractions having comparable TLCs were combined, giving 7 major "superfractions" (SF1SF7). These superfractions were then purified by recrystallization using the vapor diffusion
(vial-in-vial solvent diffusion) method (Figure 2.5). Each SF was dissolved in a small
amount of EtOAc in a small vial by gentle heating then the vial was placed in a bottle
containing pentane and kept undisturbed for 24 h to a few days to develop crystals. SF1 gave
360 mg of colorless shiny flakes of a waxy compound, SF3 gave 2.11 g of colorless
crystals and SF4 gave 15.61 g of a colorless powder. The crystals and the powder were
separated from the supernatant and dissolved in a suitable deuterated solvent (5 mg sample in
750 μL of deuterated chloroform in case of SF1 and SF3, and 5 mg sample in 750 μL of
deuterated DMSO in case of SF4) for NMR experiments.

Figure (2.5). Vial-in-vial solvent diffusion method for recrystallization.

SF2 was further fractionated on a preparative TLC plate (silica gel backed on glass w/F-254;
250µm thickness; 2020 cm) (Figure 2.6A and D). SF2 was applied as a line onto the bottom
of the plate with a capillary, and the plate was developed in a solvent chamber containing
hexane: EtOAc (85:15) to give 2 subfractions (SF2-A and SF2-B) as viewed under UV light.
The desired bands were then scraped off of the glass with a razor blade. The compounds were
separated from the adsorbent by dissolving in EtOAc and filtering from the silica gel. After
evaporation, SF2-B appeared as a colorless oily liquid with a refreshing, spicy-herbaceous
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odor. About 5 mg of SF2-B were dissolved in 750 μL of deuterated chloroform to perform
NMR experiments.
SF6 was separated using a small silica gel column (Figure 2.6B and E; silica gel: 40-63 μm
particle size and 60 Å porosity as the stationary phase; glass column: 25 cm L  2 cm D)
eluted with a step gradient of hexane/EtOAc (50% hexane, 50 mL; 40% hexane, 50 mL; 30%
hexane, 50 mL; 20% hexane, 50 mL; 100% EtOAc, 50 mL) to give 3 subfractions (SF6A-C).
After evaporation, SF6-C appeared as a colorless amorphous powder. About 5 mg of SF6-C
were dissolved in 750 μL of deuterated chloroform to perform NMR experiments. SF7 was
separated using a small silica gel column (Figure 2.6C and E; silica gel: 40-63 μm particle
size and 60 Å porosity as the stationary phase; glass column: 25 cm L  2 cm D) eluted with
hexane/EtOAc (30% hexane, 50 mL; 20% hexane, 50 mL; 10% hexane, 50 mL; 100%
EtOAc, 100 mL) to give 3 subfractions (SF7A-C). After evaporation, SF7-B appeared as a
colorless powder. About 5 mg of SF7-B were dissolved in 750 μL of deuterated chloroform
to perform NMR experiments.
2.6 Structure determination.
Structures of the purified compounds were determined using Infrared Spectrometer
(Perkin Elmer FT-IR) (Figure 2.7 (a)) and Multinuclear NMR spectroscopy (Varian
INOVA 500 MHz NMR system) (Figure 2.7 (b)). Each sample was dissolved in a
suitable deuterated solvent (7.5 mg in 750 μL solvent) and measured at 25°C. The NMR
experiments included proton (1H), carbon (13C), heteronuclear single quantum correlation
(HSQC), correlation spectroscopy (COSY), and heteronuclear multiple bond correlation
(HMBC). The NMR spectra were processed and analyzed using Mestrenova NMR
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software version 10.0. The spectral data were verified by comparing with the values
reported in the literature (Ahmad and Atta-ur-Rahman, 1994; Kalegari et al., 2011;
Swigar and Silverstein, 1981).
(A)

(B)

(C)

(D)

(E)

Figure (2.6). (A) separation of SF2, (B) separation of SF6, (C) separation of SF7, separation of SF2 using
Preparative TLC, and (E) small silica gel column.
(a)

(b)

Figure (2.7). (a) Perkin-Elmer FT-IR Spectrometer and (b) Varian 500 MHz NMR Spectrometer
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2.7 Antimicrobial Screening
The essential oils, extracts, fractions and isolated compounds were screened for
antimicrobial activity against Escherichia coli (ATCC No. 10798), Pseudomonas
aeruginosa (ATCC No. 27853), Bacillus cereus (ATCC No. 14579), Staphylococcus
aureus (ATCC No. 29213), Staphylococcus epidermidis (ATCC No. 12228), Serratia
marcescens (ATCC No. 14756), Aspergillus niger (ATCC No. 16888), Botrytis cinerea
(ATCC No. 62114) and Candida albicans (ATCC No.10231) using the microbroth
dilution technique as previously reported (Sahm and Washington, 1991; Setzer et al.,
2001).
For bacteria, 50 μL of 1% w/v solution of the samples in DMSO was placed in a well of
96 well plates and 50 μL of cation –adjusted Mueller Hinton broth (CAMHB) was added.
The sample solutions were then serially diluted (1:1) by transferring 50 μl of sampleCAMHB mixture to the next lane and adding 50 μL fresh CAMHB to obtain
concentration from 2500 μg/mL to 12.5 μg/mL. The microbes were harvested from a
fresh culture and added to each well at a concentration of approximately 1.5 x 10 8 colony
forming units (CFU)/mL. The plates were incubated at 37°C for 24 hours and the final
minimum inhibitory concentration (MIC) was determined as the lowest concentration
with no turbidity (Figure 2.8). Gentamicin was used as positive antibiotic control and
DMSO was used as negative control. Gentamicin has an MIC of 4µg/mL against P.
aeruginosa (Saeed, 2009), 4µg/mL against B. cereus (Adimpong et al., 2012) and
0.5µg/mL against E. coli (Salmon and Watts, 2000) and S. aureus (Kaya et al., 2009).
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In case of fungi, the same method described above was implemented using yeast-nitrogen
base growth medium (broth) and Amphotericin B (as positive antifungal control).
Amphotericin B had an MIC in the range of 0.5 - 4 µg/mL against Aspergillus niger
(Tokarzewski et al., 2012) and 1 mg/mL against Candida albicans (David Rogers et al.,
2003).

Concentration
2500 ppm
1250 ppm
625 ppm
312.5 ppm

MIC

156 ppm
78 ppm
39 ppm
19.5 ppm

Figure (2.8). Example of minimum inhibitory concentration (MIC) determination using microbroth
dilution assay

2.8 Cell Culture and Cytotoxicity Screening
2.8.1. Cell culture
MCF-7 (human breast cancer cells, ATCC No. HTB-22; Figure 1.3A), MDA-MB-231
(human breast cancer cells, ATCC No. HTB-26; Figure 1.3B), and 5637 (human bladder
cancer cells, ATCC No. HTB-9; Figure 1.3C) cells were used for the cytotoxicity assay
to detect the potential efficacy, the cytotoxicity profile and potential antitumor effects of
the essential oils, extracts, fractions and isolated compounds. Each cell line was grown in
38

the appropriate medium and passaged according to its type and characteristics. MCF-7
and MDA-MB-231 cells were grown in RPMI 1640 with L-glutamine (Sigma-Aldrich,
St. Louis, MO) supplemented with 10% fetal bovine serum (FBS) premium (Atlanta
Biologicals, Lawrenceville, GA), 30 mM HEPES, 7.5% sodium bicarbonate (SigmaAldrich, St. Louis, MO), 10,000 units Penicillin (Sigma-Aldrich, St. Louis, MO) and 10
mg/mL Streptomycin (Sigma-Aldrich, St. Louis, MO) at pH of 7.35 in 5% CO2
humidified atmosphere. Human bladder cancer cell line, 5637, was grown in RPMI 1640
RPMI 1640 with L-glutamine (Sigma-Aldrich, St. Louis, MO) supplemented with 10%
fetal bovine serum (FBS) premium (Atlanta Biologicals, Lawrenceville, GA), 30 mM
HEPES, 7.5% sodium bicarbonate (Sigma-Aldrich, St. Louis, MO), 1.0 mM sodium
pyruvate (Gibco® Thermo Fisher Scientific, Waltham, MA), 2.5 g/L glucose, 10,000
units Penicillin (Sigma-Aldrich, St. Louis, MO) and 10 mg/mL Streptomycin (SigmaAldrich, St. Louis, MO) at pH of 7.35 in 5% CO2 humidified atmosphere.
The stock RPMI 1640 was prepared by dissolving RPMI 1640 medium powder in 700800 mL of Ultrapure Mili-Q sterile water. Then 10 mL of 10,000 units Penicillin and 10
mg/mL Streptomycin, 15 mL of 1.0 M HEPES, and 26.7 mL of 7.5% sodium bicarbonate
were added. The pH was adjusted to 7.35 and the volume was adjusted to 1000 mL with
sterile water. The medium was sterile filtered using a 0.22µm bottle top filter (Thermo
Fisher Scientific, Waltham, MA). The stock growth medium was stored at 4°C. Feeding
medium consisted of the stock growth medium and 10% FBS.
The ampoule containing frozen cells was gently agitated and thawed as rapidly as
possible in the 37°C water bath (1-2 minutes), to minimize intracellular ice crystal
growth. The cell suspension was diluted slowly by feeding medium and centrifuged to
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remove the cryoprotectant. The cell pellet was resuspended in feeding medium. Cells
were reseeded in T-25 cell culture flasks at a concentration of 3 × 10 6 cells/mL and
incubated for 24 hours (at 37°C and 5% CO2) to let the cells attach. On the following day,
medium was replaced with 37°C fresh feeding medium. Medium was changed every 48
hours until the cells were confluent (Freshney, 2005).
2.8.2 Subculture
When the cells occupy all of the available substrate (high cell density; cells/cm 2
substrate) or when the cell concentration (cells/mL medium) exceeds the capacity of the
medium, growth can be greatly reduced. Then the culture must be divided in order to
maintain a good growth rate (Freshney, 2005). Subculture involves removal of the
medium, dissociation of the cells in the monolayer with trypsin/EDTA (Sigma-Aldrich,
St. Louis, MO), counting and reseeding the cells. All solutions and feeding medium were
warmed in a 37°C water-bath prior to use. Hanks Balanced Saline Solution (Hanks BSS)
(Ca2+,

Mg2+

free)

was

purchased

from

Sigma-Aldrich

(St.

Louis,

MO).

Trypsin/EDTA/Hanks BSS solution was prepared [1 mL of 10x Trypsin/EDTA (5g
porcine trypsin and 2g EDTA-4Na per liter of 0.9% sodium chloride solution) in 9 mL of
1x Hanks BSS] and sterilized by filtering though a sterile 0.22µm syringe filter (Fisher
Scientific, Waltham, MA). Medium was aspirated from each T-25 flask and cells were
washed gently with 5 mL of 1x Hanks BSS for about 30 sec to remove traces of medium.
The Hanks BSS solution was then aspirated and replaced with 5 mL of sterile 10%
trypsin solution. After 30 seconds, the trypsin solution was aspirated leaving a thin layer
of trypsin covering the cells. Flasks were placed in the incubator (37°C at 5% CO2) for 30
seconds to 1 minute (to loosen cells) then 5 mL of feeding medium were added to each
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flask to stop the enzymatic dissociation. FBS has been shown to contain a member of the
inter-alpha-trypsin inhibitor family (Chen et al., 1992). In case of 5637 cell line, cells
were trypsinized at 37°C and 5% CO2 for 10-12 minutes to loosen cells then 5 mL of
feeding medium were added. The solution containing cells was pipetted from the flasks
into a 50-mL conical tube and centrifuged using the IEC Clinical Centrifuge at setting
five for about 2 min. The supernatant was aspirated without disturbing pellet and cells
were resuspended in 10 mL of 1x Hanks BSS, mixed well (gently up/down with a 10-mL
pipette), and counted using a hemocytometer. For counting cells, 100 µL of well-mixed
cell suspension was added to 600 µL of 0.9% NaCl and 300 µL of sterile filtered 0.4%
trypan blue (Sigma-Aldrich, St. Louis, MO) and mixed well. A small droplet of the
mixture was added to each side of the hemocytometer (using 1-mL pipette) and viewed
under a light microscope. The number of living cells (transparent cells) in the large 8
squares (fields) was determined and their average was used to calculate cell
concentration. Depending on the cell count, cells were diluted to a concentration of 1.75
× 105 cells/mL, plated in T-25 flasks and gently agitated to ensure that cells are evenly
distributed along the bottom of the flask before placing them in the incubator (5% CO2 at
37°C). The cap was loosened to allow gas exchange (Freshney, 2005).
2.8.3. Thiazolyl Blue Tetrazolium Bromide (MTT) assay
In-vitro cytotoxic effects of C. canescens oil, extracts, and pure compounds on human
cancer cell lines’ viability was performed using the 96-well Thiazolyl Blue Tetrazolium
Bromide (MTT) assay (Berridge, Herst, and Tan 2005, (Berridge, Herst, and Tan 2005;
Palazzo et al., 2009). To prepare stock MTT solution (5 mg/mL), 0.05 g of Thiazolyl
Blue Tetrazolium Bromide (Sigma-Aldrich, St. Louis, MO) was dissolved in 10 mL of
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sterile 10mM phosphate-buffered saline (PBS; pH 7.35), then sterilized by filtering and
kept wrapped in foil due to its light sensitivity. The unused portion was frozen for future
use.
In this assay (Figure 2.9 (a)), cells were plated into 96-well cell culture plates at a
concentration of 1.2 × 104 cells/well and a volume of 100 μL in each well. The plate was
then labeled and incubated at 37°C and 5% CO2 for 48 hours. After 48 hours, the cells
reached 70-80% confluent growth. The supernatant fluid was gently aspirated (without
touching the bottom of the well to avoid removing cells) and replaced with 100 μL
growth medium containing 1 μL of test compounds [1% in dimethyl sulfoxide (DMSO)
(Sigma-Aldrich, St. Louis, MO)], giving a final concentration of 100 μg/mL (100 ppm).
Eight replicates were done for each compound. The plate was then incubated at 37°C and
5% CO2 for 48 hours. After 48 hours, the liquid was gently aspirated from each well. In a
15mL tube, 10 mL feeding medium was mixed with 2 mL of MTT stock solution (and
was protected from light). Into each well, 100 µl of the MTT solution was added and the
pre-read absorbance was immediately measured spectrophotometrically at 570 nm using
a Molecular Devices SpectraMax Plus 384 microplate reader; Figure 2.9 (b). The plate
was then incubated at 37°C and 5% CO2 for 4h during which time living cells produce
formazan crystals (Figure 2.9 (c)). After 4h, medium with MTT solution was aspirated
carefully and 100µL of DMSO were added to each well to dissolve the purple crystals.
The amount of MTT-formazan produced was determined spectrophotometrically at 570
nm. Feeding medium, 1% DMSO, and tingenone (100μg/mL) served as negative, solvent,
and positive controls, respectively. Tingenone has been shown to kill 100% of MCF-7
and MDA-MB-231 cells (Setzer et al., 2001). Solutions were added to wells in eight
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replicates. Average absorbances, standard deviations, and percent kill ratios were
calculated.

(b)

(a)
(c)
Figure (2.9). (a) Summary of MTT assay, (b) Molecular Devices SpectraMax Plus 384 Microplate reader,
and (c) Example of MTT plate.

The same assay was used to determine the IC50 of pure compounds by testing different
compound concentrations, allowing comparison of potency to other known drugs (Hill et
al., 2011). The IC50 values were determined using the Reed-Muench method which is
simple and easy to use (Reed and Muench, 1938). The method employs cumulative
values. It is assumed that an organism killed by a certain dose would have been killed by
a larger dose, and that a surviving organism would have survived a smaller dose. When
tabulating the values, the group number and dilutions (doses) are recorded in the first and
second columns respectively. The cumulative dead are recorded by adding successive
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entries in the third column of the table, and the cumulative survivors are recorded by
adding successive entries of the fourth column, upward. Doses smaller than the greatest
dose allowing all organisms to survive are neglected as they have no significance, and
doses larger than the least dose causing all organisms to die are neglected as well. The
percent survival for both doses adjacent to the IC50 is computed, and then the
proportionate distance between these two dilutions is calculated in the following mannar:

The 50% end point is then calculated in the following way:
log IC50 = (log dilution above 50%) + (proportionate distance × log dilution factor)
2.9 Brine shrimp lethality assay
The brine shrimp (Artemia salina) lethality test was carried out using a
modification of the procedure by McLaughlin (1991). A. salina eggs were hatched in
artificial sea water solution (Instant Ocean®, 38 g/L) with an incandescent light bulb as
the light/heat source. Air bubbles were introduced by a small air pump to keep the
shrimp eggs in constant motion. After 48 hours, the newly hatched nauplii were counted
in small droplets using a micropipette (Eppendorf, 2-10µL) under a stereo microscope
(Graf Apsco, D-5192) then transferred to 20-mL vials. Test samples were prepared as 1%
in DMSO and were tested at 100 µg/L and 10 µg/L. Three replicates, each containing 10
A. salina nauplii in 10 mL of sea salt solution, were prepared for each concentration. Sea
salt solution and DMSO were used as controls. Surviving A. salina nauplii were counted
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after 24 hours (Satyal et al., 2012). The IC50 values were determined using the ReedMuench method (Reed and Muench, 1938).

Figure (2.10). Summary of brine shrimp lethality assay.

2.10. Antileishmanial activity
The antileishmanial activities of the extracts were assayed by Dr. Lianet Monzote,
Parasitology Department, Institute of Tropical Medicine “Pedro Kourï”, Cuba.
2.10.1. Parasite cultures:
Leishmania amazonensis (MHOM/77BR/LTB0016) was kindly provided by the
Department of Immunology, Oswaldo Cruz Foundation (FIOCRUZ), Brazil. Parasites
were routinely isolated from mouse lesions and maintained as promastigotes at 26ºC in
Schneider’s medium (Sigma, St. Louis, MO, USA) containing 10% heat-inactivated fetal
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bovine serum (HFBS) (Sigma, St. Louis, MO, USA), 100 g of streptomycin/mL, and
100 U penicillin/mL. The parasites were not used after the tenth passage.
2.10.2. Antipromastigote assay:
Schneider’s medium (50 µL) was distributed in each well of a 96-well plate. In the first
well of each lane, 48 µL of medium and 2 µL of test products were added. Then, five
serial dilutions at a 1:2 ratio were made along each lane by taking 50 µL of the test
solution and adding 50 μL of medium each time. 50 µL of exponentially growing cells at
2  105 promastigotes/mL were added to each well to give final concentrations ranging
from 12.5 to 200 g/mL. After incubation for 72 hours at 26ºC, the medium was removed
and 20 µL of MTT solution (Sigma, St. Louis, MO, USA) was added to each well. After
incubation for an additional 3 h the formazan crystals were dissolved by addition of 100
L of DMSO. The optical density was determined using a spectrophotometer (Sirio S
Reader, 2.4-0, Italia), at a test wavelength of 560 nm and a reference wavelength of 630
nm (Sladowski et al., 1993; Dutta et al., 2005). The median inhibitory concentration
(IC50) was obtained from lineal dose-response curves fit to data by means of the lineal
equation model. The evaluations were performed in triplicates. The results are expresses
as mean  standard deviation (Bodley et al., 1995).
2.10.3. Host cytotoxicity assay:
The cytotoxic median concentration (CC50) of the extracts was determined on mouse
peritoneal macrophages, which are the host cells for the amastigote form of the parasite
to investigate the toxicity to the host cell (Sladowski et al., 1993). Resident macrophages
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were collected from peritoneal cavities of normal BALB/c mice in ice-cold RPMI 1640
medium (Sigma, St. Louis, Mo, USA) supplemented with antibiotics, and seeded at
3×104 cells/well and allowed to adhere for 2 h at 37ºC in 5% CO2. After non-adherent
cells were removed by washing with PBS, dilutions of the extracts in 2 L of DMSO
were added to 98 L medium at 10% HFBS and antibiotics. Macrophages treated with
DMSO were included as controls. Cytotoxicity was determined using the colorimetric
assay with MTT. After incubation for an additional 3 h the formazan crystals were
dissolved by addition of 100 L of DMSO. The optical density was determined at 560
nm and CC50 was obtained from dose-response curves fit to data by means of the lineal
equation model. The evaluations were performed in triplicate. The results are expresses
as mean  standard deviation.
2.10.4. Selectivity Index
The selectivity index (SI) ratio (CC50 for macrophage / IC50 for promastigotes) was used
to compare the toxicity of the extracts for murine macrophage and the activity against
intracellular amastigotes of Leishmania. Extracts with a SI  5 or with IC50 against
promastigotes were selected to follow experiment.
2.10.5. Antiamastigote assay
The peritoneal macrophages were harvested and plated at 106/mL in 24-Well Lab-Tek
(Costar, USA) and incubated at 37ºC under an atmosphere of 5% CO2 for 2 hours. Nonadherent cells were removed by washing with PBS. Stationary-phase of L. amazonensis
promastigotes were added at a 4:1 parasite/macrophage ratio and the cultures were

47

incubated for further 4 h. The cell monolayers were washed three times with PBS to
remove free parasites. Then, 1990 L of RPMI completed medium and 10 L of the
extracts dissolved in DMSO were added to each well. Four dilutions (1:2 ratio) were
carried out by taking 1000 µL each time to obtain test concentrations of the extracts
ranging from 12.5 to 100 g/mL, in duplicate cultures for 48 h (Caio et al., 1999). The
parasites were then fixed in absolute methanol, stained with Giemsa, and examined under
light microscopy. The number of intracellular amastigotes was determined by counting
the amastigotes in 25 macrophages per each sample, and the results were expressed as
percent of reduction of the infection rate in comparison to that of the controls. The
infection rates were obtained by multiplying the percentage of infected macrophages by
the number of amastigotes per infected macrophages (Delorenzi et al., 2001). The IC50
value was determined from the concentration-response lineal curves. The evaluations
were performed in triplicate. The results are expresses as mean  standard deviation.
2.11

Allelopathic Activity
An allelopathic bioassay based on lettuce (Lactuca sativa) and perennial rye grass

(Lolium perenne) germination and subsequent radicle and hypocotyl growth was used to
study the effects of the essential oils, extracts and isolated compounds (Kennedy et al.,
2011). Stock solutions of each sample (2.0 g/L of sample and 1.0 g/L of Tween-80 in
water, as an emulsifier) were prepared and used for the assays. Two-fold serial dilutions
of the stock test solutions were prepared to give test concentrations of 4000, 2000, 1000,
500, and 250µg/mL with the control being 1.0 g/L of aqueous Tween-80. Seeds were
placed in 6-inch petri dishes (10 seeds per dish), lined with two layers of Whatman No. 1
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filter paper moistened with test solution. The test plates were then sealed with Parafilm ®
and incubated at room temperature in the dark for 5 days, after which the number of
germinated seeds was determined and the root (radicle) and shoot (hypocotyl) lengths
were measured. A student’s t-test (Zar, 1996) was used to compare radicle and hypocotyl
test means with controls. Seed germination IC50 values were determined using the ReedMuench method (Reed and Muench, 1938).
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CHAPTER THREE

Results and Discussion

3.1 Essential oil composition
Leaf essential oils (Figure 3.1) of Conradina canescens were obtained in 17.6% and
13.64% product yields for the vegetative and flowering plant samples, respectively.
Chemical analysis of C. canescens essential oils (Table 3.1) revealed a variety of
terpenes, terpenic aldehydes and ketones, and terpenic alcohols. Conradina was reported
to produce large amounts of terpenes as an allelopathic weapon to inhibit the germination
and growth of nearby grasses which helps to prevent fire damage (Williamson et al.,
1989; Fischer et al., 1994) and as a chemical defense against insects (Quinn et al., 2007).
The major components of C. canescens oil were 1,8-cineole, camphor, α-pinene, pcymene, cis-pinocamphone, myrtenal, myrtenol, verbenone, and myrtenyl acetate with
other minor constituents (3% or less of each). The structures of the major compounds
can be seen in Figure (3.2). Previous studies on Conradina used the passive extraction
method in order to avoid thermal degradation of its volatile components (Peterson, 1998;
Williamson et al., 1989; Quinn et al., 2007). Our results using the hydrodistillationextraction procedure have shown that there is little loss of volatile compounds of this
plant. Interestingly, we were able to extract and identify a larger number of compounds
and larger quantities using this hydrodistillation-extraction method. Some compounds
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were not found in the reference libraries which indicates that C. canescens contains a
unique complement of volatile compounds.

Figure (3.1). C. canescens essential oil.

1,8- Cineole

camphor

α-pinene

myrtenal

myrtenol

verbenone

p-cymene

cis-pinocamphone

myrtenyl acetate

Figure (3.2). Chemical structures of major components of C. canescens oil.

The most abundant constituent was 1,8-cineole (eucalyptol), a well-known bicyclic ether
and a monoterpenoid.

1,8-Cineole was also reported as the major compound in

Eucalyptus camaldulensis and E. tereticornis (Doran and Brophy, 1990), E. globulus
(Yang et al., 2004) and Melaleuca leucadendron (Pujiarti et al., 2011). 1,8-Cineole and
camphor were also found to be the major components of Conradina brevifolia, C. glabra
and C. verticillata (Peterson, 1998). Camphor, a terpenic ketone, was the most abundant
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component of the hexane extract of Conradina etonia (Quinn et al., 2007). p-Cymene
was found in several plant species such as Tarchonanthus camphoratus (Omolo et al.,
2004), and Lantana camara (Sundufu and Shoushan, 2004).
There is a clear variation between the samples collected in 2010 and 2014 in the amount
of some constituents especially 1,8-cineole, which might be due to seasonal changes
during growth and environmental differences during the time of collection. Seasonal
differences in chemical content may reflect the change in environmental stimuli which
the plants experience. Angiosperms have been reported to exhibit variations in chemical
patterns as a response to nutrient availability and photoperiod (Krischik and Denno,
1983). Terpenoids are thought to be synthesized in accordance with seasonal fluctuations
in herbivore pressure as a means of chemical defense against herbivory during the
vulnerable periods (Langenheim, 1994). Müller-Schwarze and Thoss (2008) reported low
monoterpenoid levels in plants on rock pillars without mammalian herbivores. Another
possibility could be the normal chemical differences between individuals of the same
population as well as the chemical variations between one leaf and another on the same
individual. Terpene biosynthesis is high at the first few weeks of leaf development and
then declines to very low levels by age (Gershenzon, 1994). In addition, flowering can
be a reason for these differences. A lower level or lack of a certain component at the
time of flowering might be the result of being catabolized and used as a carbon source.
Gershenzon (1994) reported that in Mentha, about 50-75% of the monoterpenes stored in
mature leaves were degraded at the time of flowering in order to recover some of the
metabolic costs of this stage.
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The monoterpenoid major components in C. canescens compare favorably with those of
Rosmarinus officinalis (Pintore et al., 2002; Angioni et al., 2004; Celiktas et al., 2007;
Bozin et al., 2007). Thus, for example, in R. officinalis, α-pinene concentration generally
ranges 14-26%; 1,8-cineole around 1-3% in Sardinian samples (Angioni et al., 2004) and
as much as 61% in samples from Turkey (Celiktas et al., 2007); camphor around 3-24%;
borneol 2-18%; verbenone ranges from 0% to 45% in Turkish samples (Celiktas et al.,
2007); bornyl acetate about 1% in Serbian samples (Bozin et al., 2007) and 14-17% in
Corsican samples (Pintore et al., 2002); and p-cymene 0-4%. Conradina canescens may
represent, therefore, a potential herb for culinary use, herbal teas, or aromatherapy.
Table (3.1). Chemical composition of Conradina canescens essential oils.
Samples of 2010

RIa

Compound

885

Santene

1.0

916

Tricyclene

935
941

Samples of 2014
%(veg)b

%(fl)c

1.6

1.3

0.6

0.1

0.1

---

---

α-Thujene

0.7

0.3

---

0.1

α-Pinene

5.6

4.5

3.2

5.4

954

Camphene

1.2

1.3

2.0

2.1

958

Thuja-2,4(10)-diene

0.7

0.3

---

---

963

Benzaldehyde

0.2

0.3

---

---

976

Sabinene

0.4

0.4

0.2

1.0

979

β-Pinene

1.1

1.2

0.7

---

981

1-Octen-3-ol

0.2

0.2

---

---

0.5

tr

d

---

---

tr

0.4

0.3

0.9

%(veg)

b

%(fl)

c

992

Myrcene

992

Dehydro-1,8-cineole

1004

α-Phellandrene

1.7

0.3

tr

0.8

1016

α-Terpinene

0.3

0.3

---

0.1

1026

p-Cymene

5.9

6.6

3.3

12.9

1028

Limonene

tr

0.8

---

---

1029

β-Phellandrene

4.5

tr

---

---

1035

1,8-Cineole

5.2

20.5

25.2

10.7

1038

Lavender lactone

0.1

tr

---

---

1043

Phenylacetaldehyde

0.2

0.3

---

---

1048

(E)-β-Ocimene

0.2

0.2

---

---

1060

γ-Terpinene

0.4

0.2

0.1

0.4
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RIa

Samples of 2010

Compound

%(veg)

b

%(fl)

Samples of 2014
c

%(veg)b

%(fl)c

1068

cis-Sabinene hydrate

0.2

0.1

---

0.1

1070

p-Mentha-3,8-diene

---

0.1

---

---

1073

cis-Linalool oxide (furanoid)

0.9

0.1

0.5

0.9

1079

p-Cresol

0.1

---

---

---

1082

Camphenilone

0.2

0.2

---

---

1088

trans-Linalool oxide (furanoid)

1.7

tr

---

---

1090

p-Cymenene

---

1.2

1.4

1.6

1097

trans-Sabinene hydrate

0.2

0.1

---

---

1102

Linalool

0.5

tr

---

0.9

1114

1-Octen-3-yl acetate

0.2

0.1

---

---

1116

trans-Thujone (= β-Thujone)

0.2

0.1

---

---

1121

Dehydrosabina ketone

1.2

1.1

1.2

1.3

1124

cis-p-Menth-2-en-1-ol

0.2

tr

1.4

---

1127

α-Campholenal

0.8

0.7

---

1.5

1139

trans-Pinocarveol

1.4

1.6

---

---

1139

Nopinone

1.0

0.9

0.7

---

1141

cis-Verbenol

tr

0.5

---

---

1146

Camphor

5.7

4.4

8.0

6.8

1159

trans-Pinocamphone

0.3

0.2

---

---

1160

Sabina ketone

0.3

0.3

1.0

0.7

1161

Pinocarvone

0.4

0.3

---

---

1165

Borneol

1.7

1.1

---

---

1167

p-Mentha-1,5-dien-8-ol

0.7

0.8

---

---

1175

cis-Pinocamphone

1.3

2.1

5.5

2.8

1178

Terpinen-4-ol

1.6

1.4

---

2.1

1183

p-Methylacetophenone

0.3

0.4

---

---

1187

Cryptone

2.1

2.6

2.0

2.3

1188

p-Cymen-8-ol

0.8

tr

---

---

1191

α-Terpineol

1.4

1.0

---

---

1199

Myrtenal

5.2

7.6

8.1

10.2

1205

3,6,6-Trimethylnorpinan-2-one

0.5

0.6

---

---

1205

Myrtenol

9.2

3.8

3.4

4.7

1215

Verbenone

4.0

3.2

4.5

4.2

1218

trans-2-Pinanol

---

---

0.2

0.1

1224

trans-Carveol

1.2

1.0

1.3

1.1

1227

exo-2-Hydroxycineole

0.7

0.9

1.8

2.2

1228

nor-Davanone

---

0.7

---

---

1233

m-Cumenol

1.3

0.4

1.1

0.5

1240

Cuminaldehyde

1.1

1.0

0.6

1.2

1246

Carvone

0.7

0.8

0.8

0.8

1251

trans-2-Hydroxypinocamphone

0.5

0.6

1.5

0.9
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Samples of 2010

RIa

Compound

1255

Piperitone

0.2

1256

cis-Myrtanol

0.2

1264

trans-Piperitone epoxide

1274

cis-Tetrahydrojasmine

1274

p-Mentha-1-en-7-al (= Phellandral)

1278

Samples of 2014
%(veg)b

%(fl)c

0.1

---

0.3

0.3

---

---

---

---

0.3

0.3

0.8

0.9

---

---

---

---

0.5

0.6

Unidentified

0.2

0.2

1.4

1.2

1285

Bornyl acetate

0.5

0.2

0.6

0.5

1292

p-Cymen-7-ol

1.2

1.1

1.7

1.7

1299

Perilla alcohol

0.1

0.3

0.3

0.3

1299

trans-Pinocarvyl acetate

0.3

0.1

---

---

1305

Carvacrol

0.7

0.4

0.8

0.6

1327

Myrtenyl acetate

5.0

6.4

5.4

3.2

1328

p-Mentha-1,4-dien-7-ol

0.1

---

0.1

0.1

1332

3-Oxo-p-menth-1-en-7-al

0.2

0.2

0.2

0.3

1341

Piperitenone

0.1

---

0.1

0.1

1350

α-Terpinyl acetate

0.6

0.3

0.6

0.5

1361

Eugenol

---

---

---

tr

1372

4-Hydroxymyrtenal

2.6

3.1

---

---

1385

β-Bourbonene

0.1

---

1.7

2.3

1419

(E)-Caryophyllene

0.2

tr

---

0.3

1422

Chrysanthenone

---

---

---

0.1

1454

α-Humulene

0.1

---

0.1

0.1

1461

Alloaromadendrene

0.1

---

---

tr

1483

Germacrene D

1.4

0.1

0.2

0.3

1511

(E,E)-α-Farnesene

0.5

0.1

0.2

0.2

1561

1-Norbourbanone

0.1

---

---

---

1570

8-Acetoxycarvotanacetone

0.1

---

0.2

0.1

1574

Spathulenol

0.1

0.1

---

---

1585

Caryophyllene oxide

0.6

1.2

1.3

1.6

1594

Viridiflorol

0.3

---

tr

0.4

1605

Ledol

0.1

---

---

0.2

1610

Humulene epoxide II

0.2

0.4

0.2

0.2

1619

Unidentified

0.3

0.4

0.5

---

1637

Caryophylla-4(12),8(13)-dien-5-ol

0.1

---

0.1

0.2

1654

α-Cadinol

0.6

0.3

0.3

0.6

Total Identified (%)

97.4

97.8

96.1

96.9

85

72

48

57

%(veg)

Compounds Identified
a

b

%(fl)

c

RI determined with respect to a homologous series of n-alkanes on an HP-5ms column.
Sample collected in March, prior to flowering.
c
Sample collected in May, during flowering.
d
tr = “trace” (< 0.05%).
b
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The essential oils of C. canescens were screened for potential antimicrobial activity
(Table 3.2) against Escherichia coli, Pseudomonas aeruginosa, Bacillus cereus,
Staphylococcus aureus, Staphylococcus epidermidis, Serratia marcescens, Botrytis
cinerea, Aspergillus niger and Candida albicans. C. canescens essential oils showed no
antimicrobial activity (MIC = 1250 μg /mL with P. aeruginosa, S. aureus, S. epidermidis,
and C. albicans; MIC = 625 μg /mL with E. coli, S. marcescens, B. cereus and A. niger).
However, it was slightly active against B. cinerea (MIC = 156 μg/mL). Interestingly,
some of the identified constituents were reported to be effective antimicrobial agents such
as 1,8-cineole (Sökmen et al., 2004; Randrianarivelo et al., 2009; Gilles et al., 2010), αterpineol,

terpinen-4-ol, α-pinene, β-pinene, β-caryophyllene, α-phellandrene,

and p-

cymene (Dorman and Deans, 2000). One possible explanation is that the concentrations
of these components in Conradina oil were not high enough to show their antimicrobial
effects.
Table (3.2). Antimicrobial activity of C. canescens essential oil.
MIC (μg /mL)
1250
1250
1250
625
625
625
625
1250
156

Microorganism
P. aeruginosa
S. aureus
S. epidermidis
E. coli
S. marcescens
B. cereus
A. niger
C. albicans
B. cinerea

The essential oils of C. canescens were screened for in-vitro cytotoxic activity against
MCF-7 cells but showed no significant activity (0% kill at 100 µg/mL). A recent study
investigated the antileishmanial activity of 1,8-Cineole which was reported to be inactive
against Leishmania spp. (Machado et al., 2014) but α-pinene showed activity (Mikus et
56

al., 2000). Myrtenal, camphor, and verbenone have shown antitrypanosomal activity
(Nibret and Wink, 2010).
Terpenoids, especially monoterpenoids, are considered one of the 14 allelochemical
classes (Rice, 1984) that play an important role in the interactions between plants (Khan
and Ungar, 1984; Muller and Muller, 1964). Detailed knowledge of allelopathic actions
in natural plant communities can provide excellent models for new strategies in
developing highly selective herbicides. The allelochemicals found in the leaves of C.
canescens are thought to play a significant role in a healthy scrub ecosystem by inhibiting
the germination of native grasses (De la Peña, 1985). The allelopathy of C. canescens has
been reported previously (Fischer et al., 1988; Williamson et al., 1989; Fischer et al.,
1994). Water washes of fresh C. canescens leaves were strongly inhibitory due to the
presence of a series of monoterpenes, namely 1,8-cineole, camphor, borneol and αterpineol, along with a high amount of ursolic acid. 1,8-cineole, camphor and borneol are
well-known potent plant germination and growth inhibitors (Fischer et al., 1988). The
current work complements those previous reports. The allelopathic activity of essential
oil of C. canescens was evaluated on the germination and growth of Lactuca sativa
(lettuce), a dicot species and Lolium perenne (perennial ryegrass), a monocot species.
The oil showed remarkable germination inhibition of both L. sativa and L. perenne
(Table 3.3). Despite the fact that both species suffered germination inhibition, lettuce
seeds were considerably more sensitive to germination inhibition by C. canescens oil. At
concentrations of 4000-250 µg/mL, the germination of L. sativa was completely
suppressed. The IC50 values for germination inhibition were determined to be 88.39
µg/mL and 613.64 μg/mL, respectively, for L. sativa and L. perenne. Interestingly, L.
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perenne seedlings showed greater radicle growth inhibition than L. sativa. According to
Belz and Hurle (2004), root length is the most sensitive parameter which gives a reliable
response to allelochemicals. This may be due to induction of oxidative stress (Zunino and
Zygadlo, 2004), inhibition of oxygen uptake by mitochondrial suspensions (Muller et al.,
1969), and disruption of mitotic activity in growing cells (Romagni et al., 2000). The
phytotoxic activity of C. canescens oil can be attributed to the high concentration of 1,8cineole which was previously reported to inhibit the seed germination and seedling
growth of lettuce in a dose-dependent manner (Qiu et al., 2010; Nishida et al., 2005;
Zunino and Zygadlo, 2004; Singh et al., 2002; Abrahim et al., 2000). 1,8-cineole inhibits
mitochondrial respiration via uncoupling of oxidative phosphorylation and inhibition of
electron transfer (Abrahim et al., 2003) and strongly inhibits all stages of mitosis (Macias
et al., 2003). It was also reported to inhibit root growth and DNA synthesis in the root
apical meristem of Brassica campestris (Koitabashi et al., 1997) and inhibited both
proliferation and elongation of BY-2 cultured tobacco cells (Yoshimura et al., 2011).
Table (3.3). Allelopathic activity of C. canescens essential oil on lettuce (Lactuca sativa) and perennial
ryegrass (Lolium perenne).
Compound

Concentration
(µg/mL)

Essential oil
of C.
canescens

4000
2000
1000
500
250
125
62.5

Germination Inhibition (%)
Lactuca
Lolium
sativa a
perenne b
100
100
100
100
100
83.33
100
36.67
100
13.33
63.33
36.67
-

a

Seedling growth (% of controls)
Lactuca sativa
Lolium perenne
radicle
hypocotyl radicle hypocotyl
19.27c
84.16f
39.55c
84.05e
c
54.47
48.16c
d
71.04
86.98e
-

IC50 = 88.39 µg/mL, b IC50 = 613.64 µg/mL
Significance vs. controls: c P < 0.001, d 0.01< P < 0.1, e 0.1 < P < 0.5, f not significant.
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3.2. The crude extract
The dried aerial parts of C. canescens were extracted with refluxing chloroform to give
crude chloroform extract in 23.45% yield followed by methanol to give crude methanol
extract in 19.44% yield. The results of the current study showed that Conradina
canescens is a reservoir of several important bioactive molecules. Chromatographic
separation of the chloroform extract led to the identification of six compounds namely
ursolic acid, betulin, β-amyrin, myrtenic acid, n-tetracosane, and oleanolic acid. Their
structures were established on the basis of their spectral data and then verified by
comparing with those reported in the literature (Ahmad and Atta-ur-Rahman, 1994;
Kalegari et al., 2011; Swigar and Silverstein, 1981) as follows.
3.2.1 Characterization of Compound (1)

The isolated compound was obtained from SF4 (yield = 15.61g) as a colorless powder. It
is the major constituent of the chloroform extract of C. canescens representing 62.40%.
The 1H NMR spectrum (Figure 3.3) showed seven methyl groups represented by singlets
at δ1.04, 0.91, 0.89, 0.86, 0.81, 0.75 and 0.67 ppm, similar to the methyl groups attached
to a triterpenoidal nucleus. The peak at 11.93 represents the carboxylic acid proton while
the peak at 5.13 ppm represents the proton attached to a double-bonded carbon. The
doublet at δ4.29 ppm represents the alcoholic (O-H) proton.

13

C NMR spectrum (Figure

3.4) showed a total of thirty carbon atoms, which indicates a triterpene. The carbon peak
at δ 178.24 ppm indicates a carboxylic acid. The peaks at δ138.17 and 124.55 ppm
represent the alkenic carbons (C=C) comprising the double bond in urs-12-ene triterpene.
The peak at δ76.52 ppm indicates the oxygenated carbon (attached to hydroxyl group, C-
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OH). The HSQC spectrum (Figure 3.5) indicated 7 methyl groups, 9 methylene groups,
and 7 methine carbons. HMBC, COSY spectra and key HMBC and COSY correlations
are shown in Figures (3.6), (3.7) and (3.8), respectively. IR spectrum (Figure 3.9) showed
a hydroxyl group stretch at 3423 cm-1, a methylene stretch at 2929 and 2872 cm-1, C=C
stretching of terminal methylene at 1723 cm-1, and C-O stretching at 1071 cm-1.
Consequently, the compound was identified to be ursolic acid (Figure 3.10). Ursolic acid
is also known as 3β-hydroxy-urs-12-en-28-oic acid. It has a molecular formula of
C30H48O3 and a molecular weight of 456 g/mol. Experimental NMR data were compared
to that reported in the literature (Table 3.4; Ahmad and Atta-ur-Rahman, 1994; Yang et
al., 2014). The results for the IR spectrometry, 1H NMR, and

13

C NMR are presented

below:
IR νmax: 3423 (OH), 2929- 2872 (CH2), 1723-1687 (C=O), 1460, 1385, 1270, 1122, 1071
and 742 cm-1.
1

H NMR (500 MHz, DMSO-d6) δ 11.92 (1H, s), 5.12 (1H, t, J = 3.7 Hz), 4.28 (1H, d, J =

5.1 Hz), 3.01 (1H, dt, J = 10.1, 5.0 Hz), 2.50 (1H, s), 2.12 (1H, dd, J = 11.4, 1.6 Hz), 1.04
(3H, s), 0.91 (3H, s), 0.89 (3H, s), 0.86 (3H, s), 0.81 (3H, d, J = 6.4 Hz), 0.75 (3H, s),
0.67 (3H, s).
C NMR (126 MHz, DMSO-d6) δ 178.29 (C-28), 138.25 (C-13), 124.49 (C-12), 76.82

13

(C-3), 54.78 (C-5), 52.40 (C-18), 47.02 (C-9), 46.83 (C-17), 41.65 (C-14), 39.09 (C-8),
38.52 (C-20), 38.45 (C-19), 38.38 (C-4), 38.23 (C-1), 36.53 (C-10), 36.34 (C-22), 32.71
(C-15), 30.22 (C-7), 28.26 (C-23), 27.56 (C-21), 26.99 (C-2), 23.83 (C-11), 23.28 (C-27),
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22.85 (C-16), 21.10 (C-30), 18.00 (C-6), 17.03 (C-29), 16.95 (C-24), 16.08 (C-25), 15.23
(C-26).
Ursolic acid is a well-known pentacyclic triterpenoid, widely distributed in the plant
kingdom. It was reported in a number of medicinal plants such as Rosmarinus officinalis
(Al-Sereiti et al., 1999), Melaleuca leucadendron (Tsuruga et al., 1991), Ocimum
sanctum (Vetal et al., 2012), and Hyptis suaveolens (Ragasa et al., 1997). Ursolic acid
was reported to have cytotoxic, anti-mutagenic, antiviral, antimicrobial, insecticidal,
trypanocidal, antidiabetogenic and anti-invasive activities (Novotný et al., 2001; Abe et
al., 2002; Babalola and Shode, 2013). It acts as an anti-inflammatory agent by inhibiting
histamine release and inhibiting lipoxygenase and cyclooxygenase activities (Ikeda et al.,
2008). It is also known for its hepatoprotective effects against both acute chemically
induced liver injury and chronic liver fibrosis and cirrhosis (Liu, 1995). Moreover,
ursolic acid and its isomer, oleanolic acid, were reported to have an antihypertensive
effect due to their potent diuretic-natriuretic-saluretic activity, direct cardiac effect,
antihyperlipidemic, antioxidant, and hypoglycemic effects (Somova et al., 2003). Felizola
(2015) has reported great potential benefits of ursolic acid as a therapeutic agent in
obesity/overweight, diabetes and metabolic syndrome as it reduces adipogenesis and
body fat percentage while increasing muscle mass in rodent and human models.
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Table (3.4). NMR assignment of Compound (1) (Ursolic Acid)
Position
1
2
3

sample
38.34
26.98
76.81

Carbon δ 13C
Yang et al., 2014
38.23
27.40
76.82

4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19

38.37
54.76
17.99
32.69
39.09
47.00
36.52
22.84
124.55
138.17
41.63
27.53
23.79
46.81
52.36
38.49

38.35
54.77
17.97
32.77
39.09
47.00
36.51
23.30
124.54
138.18
41.62
28.10
23.82
46.81
52.37
38.42

20
21
22
23
24
25
26
27
28
29
30

38.42
30.16
38.22
28.25
16.07
15.22
16.91
23.26
178.24
17.01
21.07

38.48
30.17
36.29
28.23
15.90
15.18
16.90
23.24
178.13
16.97
21.10

sample

Proton δ 1H
Yang et al., 2014

3.01,
4.28

CHOH: 3.33 (1H, dt, J = 10.1, 5.0 Hz)
CHOH: 4.29 (1H, d, J = 5.1 Hz)

5.12

5.12 (1H, t, J = 3.7 Hz)

2.50

2.52 (1H, s)

0.89
0.67
0.86
0.75
1.04
11.92
0.81
0.91

0.86 (3H, s)
0.68 (3H, s)
0.74 (3H, s)
0.75 (3H, s)
1.04 (3H, s)
11.92
0.81 (3H, d, J = 6.4 Hz)
0.91 (3H, s)
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Figure (3.3). Proton spectrum of compound (1)

Figure (3.4). Carbon spectrum of compound (1)
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Figure (3.5). HSQC spectrum of compound (1)

Figure (3.6). HMBC spectrum of compound (1)
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Figure (3.7). COSY spectrum of compound (1)

Figure (3.8). Key HMBC and COSY correlations of compound (1)
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Figure (3.9). IR spectrum of compound (1)

Figure (3.10). Chemical structure of ursolic acid.

3.2.2 Characterization of compound (2)

The isolated compound was obtained from SF3 (yield = 2.11g) as colorless crystalline
solid that turned white upon drying. The 1H NMR spectrum (Figure 3.11) showed six
methyl groups represented by singlets at δ 1.68, 1.02, 0.96, 0.93, 0.82 and 0.76 ppm,
similar to the methyl groups attached to a triterpenoidal nucleus. The doublets present at
δ 4.73 and 4.60 ppm represent the olefinic protons (-C=CH2). These doublets along with
the methyl group at δ 1.68 ppm, suggest that the compound is a lupeol-type triterpene
derivative. Another pair of doublets at δ3.78 and 3.32 ppm, rather than a seventh methyl
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singlet, confirms the presence of a second hydroxyl group. A doublet of doublets was
present at δ 3.20 ppm, which is characteristic of an α-oriented proton (directly attached to
C–O carbon) at C-3 of a 3β-hydroxy triterpene. 13C NMR spectrum (Figure 3.12) showed
a total number of thirty carbon atoms, which indicates a triterpene. The carbon peaks at δ
150.60 and 109.83 ppm represent the characteristic pair of alkenic carbons (C=C)
comprising the double bond of lupeol-type. The peaks at δ 79.14 and 60.69 ppm represent
the oxygenated carbon (attached to hydroxyl group, C-OH). The HSQC spectrum (Figure
3.13) indicated the presence of 6 methyl groups, 12 methylene groups, and 6 methine
groups. HMBC spectrum and selected correlations are shown in Figures (3.14) and
(3.15). The COSY spectrum (Figure 3.16) revealed two mutually coupled doublets (J=
11.0 Hz) at δ 3.32 and 3.78 which could be attributed to the oxymethylene protons at C28. The IR spectrum (Figure 3.17) showed a hydroxyl group stretch at 3430 cm-1 (OH), a
methylene stretch at 2939 and 2926 cm-1, C=C stretching of terminal methylene at 1682
cm-1, C-O stretching of secondary OH at 1106 cm-1, C-O stretching of primary OH at
1042 cm-1, and out-of-plane ending of the terminal methylene at 883 cm-1. In summary,
the spectra revealed a compound with thirty carbon atoms, six methyl groups, a lupenetype triterpenoid with two hydroxyl groups. Consequently, the compound was determined
to be betulin (Figure 3.18). Experimental NMR data was compared to that reported in the
literature and all

13

C shifts were within ± 0.3 ppm (Table 3.5; Ahmad and Atta-ur-

Rahman, 1994; Tijjani et al., 2012). The results for the 1H NMR,

13

C NMR and IR

spectrometry are presented below:
IR νmax: 3430 (OH), 2939, 2868 (CH2), 1682 (C=C stretching of terminal methylene),
1448, 1375 (asym and sym CH3), 1235, 1106 (C-O stretching of secondary OH), 1042
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(C-O stretching of primary OH), and 883 (out-of-plane ending of the terminal methylene)
cm-1
1

H NMR (500 MHz, CDCl3) δ: 4.73 and 4.60 (each 1H, d, J29A,29B = 1.5 Hz, H-29), 3.78

and 3.32 (each 1H, d, J28A,28B = 11 Hz, H-28), 3.20 (1H, dd, J3α,2β = 10 Hz, J3α,2α = 4.7 Hz,
H-3α), 2.41 (1H, ddd, J19,18 = J19,21β = 11 Hz, J19,21α = 5.5 Hz, H-19), 1.68 (3H, s, H-30),
1.02 (3H, s, H-27), 0.96 (3H, s, H-26), 0.93 (3H, s, H-23), 0.82 (3H, s, H-25) and 0.76
(3H, s, H-24).
C NMR (126 MHz, CDCl3) δ: 150.60 (C-20), 109.83 (C-29), 79.14 (C-3), 60.69 (C-28),

13

55.43 (C-5), 50.54 (C-9), 48.90 (C-19), 47.92 (C-18,17), 42.86 (C-14), 41.06 (C-8),
39.01(C-1), 38.85 (C-4), 37.45 (C-10), 37.30 (C-13), 34.38 (C-7), 34.12 (C-22), 29.89
(C-21), 29.32 (C-16), 28.13 (C-23), 27.52 (C-2), 27.19 (C-15), 25.35 (C-12), 20.98 (C11), 19.23 (C-30), 18.45 (C-6), 16.2 (C-25), 16.13 (C-26), 15.51(C-24), and 14.91 (C27).
Betulin is also known as betuline, betulinol, 3β,28-dihydroxylup-20(29)-ene. It has a
molecular formula of C30H50O2 and a molecular weight of 442 g/mol. It represented
8.41% of the C. canescens extract in this study which makes it the second major
constituent. It is an abundant naturally-occurring pentacyclic triterpene with a lupane
skeleton. It was isolated for the first time as a pure compound from birch bark (Betula
utilis) in 1788 (Hayek et al., 1989; Rhourri-Frih et al., 2008). It was also found in the
bark of Betula platyphylla (Wu et al., 2014) and bark of Adenium obesum (Tijjani et al.,
2012). Betulin is used as a precursor for production of betulinic acid and other highly
active derivatives (Sami et al., 2006). Betulin has three active positions in its structure, a
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secondary OH group at C-3, a primary OH group at C-28 and a double bond at C-20,
where chemical modulations can be performed in order to obtain different types of
derivatives (Alakurtti et al., 2006). Betulin and its derivatives possess anti-inflammatory,
antiviral, anti-HIV, antimicrobial, antimalarial, hepatoprotective and cytotoxic effects
(Flekhter et al., 2005; Dzubak et al., 2006). Recently, betulin was reported to protect
mice from bacterial pneumonia and acute lung injury (Wu et al., 2014).
Table (3.5). NMR assignment of Compound (2) (betulin)
Position
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17, 18
19
20
21
22
23
24
25
26
27
28
29
30

Sample
39.10
27.52
79.14
38.85
55.43
18.45
34.38
41.06
50.54
37.45
20.98
25.35
37.30
42.86
27.19
29.32
47.92
48.90
150.60
29.89
34.12
28.13
15.51
16.25
16.13
14.91
60.69
109.83
19.23

Carbon δ 13C
Tijjani et al., 2012
38.9
27.5
79.0
38.8
55.4
18.4
34.3
41.0
50.5
37.4
20.9
25.3
37.2
42.8
27.1
29.3
47.9
48.8
150.6
29.8
34.1
28.1
15.4
16.2
16.1
14.8
60.6
109.8
19.2

Sample
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Proton δ 1H
Tijjani et al., 2012

3.20

3.18 (1H, dd)

0.93
0.76
0.82
0.96
1.02
3.78; 3.32
4.73; 4.60
1.68

0.92 (3H, s)
0.75 (3H, s)
0.81 (3H, s)
0.96 (3H, s)
1.01 (3H, s)
3.79 (1H, d); 3.33 (1H, d)
4.72 (1H, d); 4.58 (1H, d)
1.68 (3H, s)

Figure (3.11). Proton spectrum of compound (2)

Figure (3.12). Carbon spectrum of compound (2)
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Figure (3.13). HSQC spectrum of compound (2)

Figure (3.14). HMBC spectrum of compound (2)
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Figure (3.15). Selected HMBC correlations of compound (2).

Figure (3.16). COSY spectrum of compound (2)
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Figure (3.17). IR spectrum of compound (2)

Figure (3.18). Chemical structure of Betulin.

3.2.3 Characterization of Compound (3)

The isolated compound was obtained from SF7-B (yield = 1.15 g) as a colorless powder.
The 1H NMR spectrum (Figure 3.19) showed eight methyl groups represented by singlets
at δ 1.14, 0.99, 0.96, 0.93, 0.86, 0.82 and 0.78 ppm, similar to the methyl groups attached
to a triterpenoidal nucleus. The peak at 5.25 ppm represents the proton attached to a
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double-bonded carbon. One methine proton at δ3.22 showed that there is at least one
hydroxyl group. Major

13

C NMR values were obtained using the HSQC and HMBC

spectra. A total of 30 carbon atoms indicated a triterpene. The carbon signals at δ145.1
and 121.8 ppm represent the alkenic carbons (C=C) comprising a double bond. The peak
at δ79.0 ppm indicates the oxygenated carbon (attached to hydroxyl group, C-OH). The
HSQC spectrum (Figure 3.20) indicated 8 methyl groups, 10 methylene groups, and 5
methine carbons. HMBC and COSY spectra are shown in Figures (3.21) and (3.22)
respectively. The IR spectrum (Figure 3.23) shows the presence of a hydroxyl function
and the olefinic moiety at a spectrum of 3360 and 1650 cm-1 (Lin et al., 2011). Based on
the spectral analysis, the compound was determined to be β-amyrin (Figure 3.24). βAmyrin is one of the common triterpenes. It was also reported in Eucalyptus globulus
(Domingues et al., 2010), and Nelumbo nucifera (Xu et al., 2011). β-Amyrin is also
known as 3β- hydroxy-olean-12-en-3-ol, β-amyrenol, β-amirin, β-amyrine, olean-12-en3β-ol, and 3β-hydroxyolean-12-ene. It has a molecular formula of C30H50O and a
molecular weight of 426.73 g/mol. It represented 4.60% of the C. canescens extract in
this study. Experimental NMR data was compared to that reported in the literature (Table
3.6; Lin et al., 2011). The results for the IR spectrometry, 1H NMR, and

13

C NMR are

presented below:
IR (KBr): 3360 (OH), 1790, 1708, 1663, 1650 and 1620 cm-1.
1

H NMR (500 MHz, CDCl3) δ 5.25 (1H, t, J=4.0 Hz, H-12), 3.22 (1H, m, W1/2=12.0 Hz,

H-3), 1.14 (3H, s, H-27), 0.99 (3H, s, H-26), 0.96 (3H, s, H-23), 0.93 (3H, s, H-25), 0.86
(6H, s, H-30, 29), 0.82 (3H, s, H-28) and 0.78 (3H, s, H-24).

74

C NMR (126 MHz, CDCl3) δ 145.14 (C-13), 121.83 (C-12), 79.04 (C-3), 55.32 (C-5),

13

47.63 (C-9), 47.34 (C-18), 46.87 (C-19), 41.83 (C-14), 38.78 (C-4), 38.63 (C-8, 1), 37.54
(C-10), 37.23 (C-22), 34.84 (C-21), 33.30 (C-29), 32.77 (C-7), 32.51 (C-17), 31.13 (C20), 28.44 (C-28), 28.18 (C-23), 27.28 (C-2), 27.03 (C-16), 26.20 (C-15), 26.06 (C-27),
23.75 (C-30), 23.62 (C-11), 18.51 (C-6), 16.92 (C-26), 15.63 (C-25) and 15.47 (C-24).
Table (3.6). NMR assignment of Compound (3) (β-amyrin)
Position
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30

Carbon δ 13C
Sample
Lin et al., 2011
38.63
38.7
27.28
27.3
79.04
79.0
38.78
38.8
55.32
55.3
18.51
18.5
32.77
32.8
38.63
38.7
47.63
47.7
37.54
37.6
23.62
23.6
121.83
121.8
145.14
145.1
41.83
41.8
26.20
26.2
27.03
27.0
32.51
32.5
47.34
47.3
46.87
46.9
31.13
31.1
34.84
34.8
37.23
37.2
28.18
28.2
15.47
15.5
15.63
15.6
16.92
16.9
26.06
26.0
28.44
28.4
33.30
33.3
23.75
23.7
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Proton δ 1H
Sample
Lin et al., 2011

3.22

3.20 (1H, m)

5.25

5.25 (1H, t)

0.96
0.78
0.93
0.99
1.14
0.82
0.86

0.96 (3H, s)
0.78 (3H, s)
0.93 (3H, s)
0.99 (3H, s)
1.14 (3H, s)
0.82 (3H, s)
0.86 (6H, s)

1
Figure (3.19). Proton spectrum of compound (3)

Figure (3.20). HSQC spectrum of compound (3)
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Figure (3.21). HMBC spectrum of compound (3)

Figure (3.22). COSY spectrum of compound (3)
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Figure (3.23). IR spectrum of compound (3)

Figure (3.24). Chemical structure of β-amyrin.

3.2.4 Characterization of compound (4)
The isolated compound was obtained from SF2-B (yield = 720 mg) as a colorless oily
liquid with a refreshing, spicy-herbaceous odor. The 1H NMR spectrum (Figure 3.25)
showed two methyl groups represented by singlets at δ1.33 and 0.79 ppm. The peak at δ
9.19 represents carboxylic acid proton while the peak at 6.97 ppm represents the proton
attached to a double-bonded carbon.

13

C NMR spectrum (Figure 3.26) showed a total
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number of ten carbon atoms, which indicates a monoterpene. The carbon peak at δ 171.64
ppm indicates a carboxylic acid. The peaks at δ 139.93 and 139.38 ppm represent alkenic
carbons (C=C). The HSQC spectrum (Figure 3.27) indicated 2 methyl groups, 2
methylene groups, and 3 methine carbons. The HMBC, COSY and IR spectra are shown
in Figures (3.28), (3.29), and (3.30) respectively. The compound was determined to be
myrtenic acid (Figure 3.31). Myrtenic acid is a derivative of myrtenal, which is a bicyclic
monoterpene. Myrtenic acid was reported as one of the volatile components of Hyssopus
officinalis (Khan and Abourashed, 2011). It is a product of pinene degradation (Figure
3.32). Myrtenic acid is also known as 6,6-dimethylbicyclo[3.1.1]hept-2-ene-2-carboxylic
acid, mirtensaeure, pin-2-en-10-saeure, and pin-2-en-10-oic acid. It has a molecular
formula of C10H14O2 and a molecular weight of 166.22 g/mol. It represented 2.88% of the
C. canescens extract in this study. The results for the IR spectrometry, 1H NMR, and 13C
NMR values are presented below:
IR νmax: 2922, 2608, 1677, 1622, 1421, 1265 and 737 cm-1
1

H NMR (500 MHz, CDCl3) δ: 9.19 (1H, s, H-1), 6.97 (H-3), 2.79 (H-2), 2.77 (H-4, H-

4′), 2.49 (H-7′), 2.39 (1H, s, H-5), 1.33 (3H, s, CH3), 1.12 (1H, d, H-7), 0.79 (3H, s, CH3)
C NMR (126 MHz, CDCl3) δ: 171.64 (C-1), 139.93 (C-2), 139.38 (C-3), 41.04 (C-4),

13

40.36 (C-5), 37.81 (C-6), 32.48 (C-7), 31.40 (C-8), 25.99 (C-9), 21.07 (C-10).
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Figure (3.25). Proton spectrum of compound (4)

Figure (3.26). Carbon spectrum of compound (4)
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Figure (3.27). HSQC spectrum of compound (4)

Figure (3.28). HMBC spectrum of compound (4)
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Figure (3.29). COSY spectrum of compound (4)

Figure (3.30). IR spectrum of compound (4).
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Figure (3.31). Chemical structure of myrtenic acid.

Figure (3.32). α-Pinene degradation and formation of myrtenic acid.

3.2.5 Characterization of compound (5)
The isolated compound was obtained from SF1 (yield = 360 mg) as colorless shiny flakes
of a waxy compound. The 1H NMR spectrum (Figure 3.33) showed signals in the range
0.8 – 1.7 ppm indicating a region characteristic of aliphatic alicyclic compounds. There
are 6 protons at δ 0.8 corresponding to terminal methyl groups and about 44 protons at
δ1.26, corresponding to CH2. The 13C NMR spectrum (Figure 3.34) showed four signals
in the range δ 14-32 ppm and overlapped signals at δ 29.6. The HSQC, HMBC, COSY
and IR spectra are shown in Figures (3.35), (3.36), (3.37), and (3.38) respectively. In
summary, the spectra revealed an aliphatic alicyclic hydrocarbon with two methyl groups
but it was difficult to estimate the number of the carbon atoms due to the overlapped
signals at δ 29.6. In order to identify the compound, it was dissolved in a small amount of
dichloromethane and analysed by GC/MS. The chromatogram and library search results
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are shown in Figure 3.39. The compound was determined to be n-tetracosane (Figure
3.40). n-Tetracosane is a straight-chain C24 alkane that has been identified as a
component in several plant essential oils such as Tipuana tipu (Kansoh et al., 2009) and
Balanites aegyptiaca (Al Ashaal et al., 2010). n-Tetracosane has a molecular formula of
C24H50 and a molecular weight of 338.65 g/mol. It represented 1.44% of the C. canescens
extract in this study. These results were in line with those of Siddiqui et al. (2004) and
Kalegari et al. (2011) (Table 3.7). The results for the IR spectrometry, 1H NMR, and 13C
NMR are presented below:
IR νmax: 2918, 2848 (CH2) cm-1
1

H NMR (500 MHz, CDCl3) δ: 1.26 (44H, s), 0.87-0.9 (6H, t, J=6 Hz).
C NMR (CDCl3; 126 MHz) δ: 32.10 (CH2), 29.88 (CH2), 22.87 (CH2), 14.28 (CH3, C-1,

13

C-24).

Table (3.7). NMR assignment of compound (5) (n-Tetracosane)
Carbon δ 13C
sample
Kalegari et al., 2011
32.10
32.1 (CH2, C-3,C-22)
29.88
29.6 (CH2, C-4-21)
22.87
22.9 (CH2, C-2,C-23)
14.28
14.3 (CH3, C-1,C-24)

Proton δ 1H
Sample
1.26
0.87
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Kalegari et al., 2011
1.26 (44H, s, C-2-23)
0.84 (6H, t, C-1, C-24)

Figure (3.33). Proton spectrum of compound (5)

Figure (3.34). Carbon spectrum of compound (5).
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Figure (3.35). HSQC spectrum of compound (5)

Figure (3.36). HMBC spectrum of compound (5)
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Figure (3.37). COSY spectrum of compound (5)

Figure (3.38). IR spectrum of compound (5).
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(a)

(b)

Figure (3.39). (a) GC-MS chromatogram of compound (5), and (b) compound library search results.

Figure (3.40). Chemical structure of n-tetracosane.

3.2.6 Characterization of Compound (6)

The isolated compound was obtained from SF6-C (yield= 260 mg) as a colorless
amorphous powder. The 1H NMR spectrum (Figure 3.41) showed seven tertiary methyl
groups at δ0.75, 0.77, 0.90, 0.91, 0.93, 0.98 and 1.25, similar to the methyl groups
attached to an oleanane triterpenoidal skeleton. A doublet doublet of one proton at δ2.82
and a triplet of one vinyl proton at δ5.27 suggest an olea-12-ene skeleton. One methine
proton at δ3.23 showed that there is at least one hydroxyl group. The peak at δ9.50
represents carboxylic acid proton. HSQC (Figure 3.42) and HMBC (Figure 3.43) spectra
were used to get the values of carbon signals. There were thirty carbon atoms, confirming
a triterpene. The signal at δ180.2 corresponds to the carboxyl group. The peaks at
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δ143.27 and 121.74 ppm represent the alkenic carbons (C=C) comprising the double
bond. The chemical shifts at δ180.2, 143.27 and 121.74 ppm were the characteristic
peaks for oleanolic type of skeleton. The peak at δ77.98 ppm indicates the oxygenated
carbon (attached to hydroxyl group, C-OH). The HSQC spectrum indicated 7 methyl
groups, 10 methylene groups, and 5 methine carbons. COSY and IR spectra are shown in
Figures (3.44) and (3.45). The IR spectrum showed a hydroxyl group stretch at 3426 cm1

, a methylene stretch at 2936 and 2864 cm-1, C=O stretching at 1698 cm-1, and C-O

stretching at 1032 cm-1.
The spectral data were similar to the ones reported for oleanolic acid (Table 3.8; Ahmad
and Atta-ur-Rahman, 1994; Güvenalp et al., 2009). Oleanolic acid (Figure 3.46) is a
pentacyclic triterpenoid with widespread occurrence throughout the plant kingdom (Liu,
1995; Xu et al., 2014), and the main source of this compound is plants belonging to
Oleaceae such as Olea europaea (olive) (Sporn et al., 2011). It is also known as 3βhydroxy-olean-12-en-28-oic acid, oleanic acid, and caryophyllin. It has a molecular
formula of C30H48O3 and a molecular weight of 456.7 g/mol. It counted for 1.04% of the
C. canescens extract in this study. The results for the IR spectrometry, 1H NMR, and 13C
NMR are presented below:
IR νmax: 3426 (OH), 2936 and 2864 (CH2), 1698 (C=O), 1462 (OH), 1376 (CH3), 1108
(C-O), 1032, 997 and 736 cm-1
1

H NMR (500 MHz, CDCl3) δ 9.50, 5.27(1H, t, J=3.5, H-12), 3.23(1H, dd, J=11.2, 4.4

Hz, H-3), 2.82 (1H, dd, J=3.6, 13.2Hz, H-18), 1.25 (3H, s, H-27), 0.98, 0.92, 0.91, 0.90,
0.77, 0.75 (each 3H, s, CH3 ×6).
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13

C-NMR (126 MHz, CDCl3): 180.2(C-28), 143.27(C-13), 121.74(C-12), 77.98(C-3),

55.8(C-5), 48.2(C-9), 46.7(C-17), 46.5(C-19), 42.2(C-14), 42.0(C-18), 39.8(C-8), 39.4(C4), 39.0 (C-1), 37.4(C-10), 34.3(C-21), 33.3(C-7, 29), 33.2(C-22), 31.0(C-20), 28.8(C23), 28.4(C-15), 28.2(C-2), 26.2(C-27), 23.8(C-16, 30), 23.7(C-11), 18.8(C-6), 17.5(C26), 16.6(C-24), 15.6(C-25).
Oleanolic acid and its derivatives have shown many pharmacological activities such as
anti-inflammatory, antioxidant, anticancer, and hepatoprotective effects. In plants, the
biological roles of oleanolic acid are thought to be associated with the formation of a
barrier against water loss and pathogens (Heinzen et al., 1996). There are many
incidences in which co-occurrence of oleanolic acid and its isomer, ursolic acid, because
they share similar structural features.

Table (3.8). NMR assignment of compound (6) (Oleanolic Acid).
Position
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18

Sample
37.9
28.2
77.98
39.4
55.8
18.8
33.3
39.8
48.2
37.4
23.7
121.74
143.27
42.2
28.4
23.8
46.7
42.0

Carbon δ 13C
Güvenalp et al., 2009
38.6
26.7
78.5
39.2
55.5
18.3
32.6
39.6
48.1
37.0
22.7
122.4
144.1
42.0
27.7
22.8
46.7
41.5

Proton δ 1H
Sample

Güvenalp et al., 2009

3.23 (1H, dd, J=11.2/4.4 Hz)

3.21 (1H, dd, J=10.2/4.4 Hz)

5.27 (1H, t, J=3.5 Hz)

5.24 (1H, t, J=3.6 Hz)

2.82 (1H, dd, J=3.6, 13.2Hz)

2.82 (1H, dd, J=12.7/4.3 Hz)
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19
20
21
22
23
24
25
26
27
28
29
30

46.5
31.0
34.3
33.2
28.8
16.6
15.6
17.5
26.2
180.2
33.3
23.8

46.1
30.4
33.7
32.3
28.8
14.7
15.1
16.5
25.2
180.4
32.8
23.3

0.98 (3H, s)
0.77 (3H, s)
0.90 (3H, s)
0.75 (3H, s)
1.25 (3H, s)

0.96 (3H, s)
0.78 (3H, s)
0.84 (3H, s)
0.76 (3H, s)
1.25 (3H, s)

0.91 (3H, s)
0.92 (3H, s)

0.87 (3H, s)
0.93 (3H, s)

Figure (3.41). Proton spectrum of compound (6).
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Figure (3.42). HSQC Spectrum of compound (6).

Figure (3.43). HMBC spectrum of compound (6).
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Figure (3.44). COSY spectrum of compound (6).

Figure (3.45). IR spectrum of compound (6).
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Figure (3.46). Chemical structure of oleanolic acid.

3.3 Antimicrobial activity
The crude extracts of C. canescens as well as the isolated compounds were screened for
antibacterial (Table 3.9) and antifungal activities (Table 3.10). The chloroform and
methanol crude extracts were active against Botrytis cinerea (MIC = 156 μg/mL and
MIC= 78 μg/mL, respectively). n-Tetracosane showed antibacterial activity against
Staphylococcus aureus and S. epidermidis (MIC = 78 μg/mL) and antifungal activity
against Aspergillus niger (MIC = 156 μg/mL) and B. cinerea (MIC = 78 μg/mL).
Myrtenic acid was active against S. aureus (MIC = 156 μg/mL), A. niger (MIC = 78
μg/mL), B. cinerea (MIC = 78 μg/mL) and Candida albicans (MIC = 156 μg/mL). The
selective activity of ursolic acid against S. aureus (MIC = 156 μg/mL) is consistent with
the literature (Wolska et al., 2010). Oleanolic acid showed activity against S. aureus and
Pseudomonas aeruginosa (MIC = 156 μg/mL). Duric et al. (2013) reported antibacterial
activity of oleanolic acid against S. aureus and Bacillus subtilis. β-amyrin showed
activity against S. epidermidis (MIC = 156 μg/mL). Betulin was not active in these
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bioassays. A previous study has reported low activity for betulin against S. aureus, E.
coli and P. aeruginosa (MIC = 0.25 mg/mL) (Magina et al., 2012).
Table (3.9). Antibacterial activity (as MIC in μg/mL) of C. canescens crude extracts and isolated
compounds.
Compound/organism

B. cereus

S. aureus

S. epidermidis

S. marcescens

P. aeruginosa

E. coli

Chloroform extract

>2500

625

>2500

>2500

312.5

>2500

Methanol extract

1250

312.5

312.5

312.5

1250

625

β-Amyrin

625

>2500

156

312.5

312.5

625

Betulin

1250

312.5

>2500

>2500

1250

>2500

Myrtenic acid

312.5

156

>2500

>2500

625

>2500

n-Tetracosane

625

78

78

312.5

312.5

625

Oleanolic acid

312.5

156

>2500

>2500

156

1250

Ursolic acid

>2500

156

>2500

>2500

312.5

>2500

Table (3.10). Antifungal activity (as MIC in μg/mL) of C. canescens crude extracts and isolated
compounds.
Compound/organism

C. albicans

A. niger

B. cinerea

Chloroform extract

1250

1250

156

Methanol extract

625

312.5

78

β-Amyrin

625

625

312.5

>2500

>2500

312.5

Myrtenic acid

156

78

78

n-Tetracosane

312.5

156

78

Oleanolic acid

1250

1250

Ursolic acid

>2500

>2500

312.5
312.5

Betulin

3.4 Cytotoxic activity
The results of the cytotoxicity testing of the crude extracts and the isolated compounds on
MCF-7, MDA-MB-231 and 5637 cell lines are shown in Tables (3.11) and (3.12). The
crude chloroform extract showed a significant activity against all cell lines. The strong
cytotoxic effects of betulin and ursolic acid against all used cell lines is in accordance
with the literature. Ursolic acid proved to be a potent anti-tumor agent that acts at various
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stages of tumor development (Ovesná et al., 2004). It can block the cell cycle progression
in the G1 phase (Ma et al., 2005), trigger apoptosis in tumor cells and prevent malignant
transformation of normal cells (Novotný et al., 2001). Siqueira et al. (2011) reported that
ursolic acid was cytotoxic against UACC-62 (human melanoma), MCF-7 and TK-10
(human renal cancer) (IC50 ranging from 10.83 to 12.83 μg/mL). Also, ursolic acid has
shown a significant cytotoxic activity against several tumor cell lines including HL-60,
K562, M4Beu, and HSC-2, with IC50 values ranging from 5.0 to 29.0 μg/mL. The
cytotoxic properties of betulin against various melanoma, neuroectodermal and malignant
brain tumor cell lines, have been well documented (Zuco et al., 2002). The mechanism of
action of betulin and its derivatives has been related to apoptosis (Fulda and Kroemer,
2009). n-Tetracosane was reported to have a significant selective cytotoxic effect (IC50 =
128.7 μM) only against HT-29 colon cancer cells and no activity against MCF-7 and
MDA-MB-231 (Uddin et al., 2012).
Table (3.11). Cytotoxic effect (as %Kill) of C. canescens crude extracts on human breast cancer (MCF-7
and MDA-MB-231) and bladder cancer (5637) cell lines.

%Kill
Chloroform extract
Methanol extract

MCF-7
98.76±1.84
16.72±19.73

MDA-MB-231
89.99 ±5.51
12.92 ±8.82

5637
83.13 ± 8.45
13.57 ± 4.45

Table (3.12). Cytotoxic effect (IC50 as µg/mL) of compounds isolated from chloroform extract of C.
canescens on human breast cancer (MCF-7 and MDA-MB-231) and bladder cancer (5637) cell lines.

β –Amyrin
Betulin
Myrtenic acid
Oleanolic acid
n-Tetracosane
Ursolic acid

IC50 as µg/mL
MDA-MB-231
>100
3.96 ± 0.23
>100
>100
>100
14.82 ± 0.96

MCF-7
>100
8.21 ± 0.48
>100
>100
>100
14.93 ± 0.48
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5637
>100
1.29 ± 0.12
>100
>100
>100
18.77 ± 0.35

3.5 Brine shrimp lethality
The brine shrimp lethality assay is thought to be one of the essential preliminary assays in
the study of potential biological activities of compounds (Kalegari et al., 2011). Table
(3.14) shows that C. canescens chloroform extract, β-Amyrin, n-tetracosane, ursolic acid
and oleanolic acid demonstrated moderate activities on A. salina nauplii.

Table (3.14). Brine shrimp lethality of C. canescens extract and isolated compounds.
LC50 ± SD
in µg/mL

Compound/extract
Methanol extract

689.11 ± 155.44

Chloroform extract

26.98 ± 1.17

β-Amyrin

20.54 ± 0.0

Betulin

388.71 ± 72.48

Myrtenic acid

291.90 ± 88.81

n-Tetracosane

40.76 ± 2.83

Oleanolic acid

12.97 ± 0.37

Ursolic acid

18.19 ± 1.00

3.6 Antileishmanial activity
The results of the antileishmanial testing of the plant crude extracts are shown in Table
(3.13). The crude extracts showed promising antileishmanial activity against
promastigotes and intracellular amastigotes

of

Leishmania amazonensis. The

dichloromethane extract showed some cytotoxicity on the host cells (CC50 = 63.7
μg/mL). The antileishmanial activity of the non-polar extract could be attributed to the
presence of ursolic acid and betulin as the major constituents. Ursolic acid isolated from
Miconia langsdorffii showed activity against L. amazonensis (IC50 = 360.3 μM) (Peixoto
et al., 2011). Interestingly, a synergistic effect was observed when ursolic acid and its
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isomer oleanolic acid were combined (IC50 =199.6 μg/mL) (Peixoto et al., 2011). Also,
the antileishmanial activity of ursolic acid against promastigotes of L. donovani (IC50 =
3.5μg/ml) (Moulisha et al., 2010) and L. major (IC50 = 21 μg/mL) (Takahashi et al.,
2004) have been reported. Betulin and its derivatives proved to be active against
Leishmania donovani and Leishmania tropica (IC50 = 14.6 µM) (Wert et al., 2011;
Haavikko et al., 2014). Betulin derivatives were efficiently able to decrease the load of
parasites infecting the host cell, without affecting macrophage viability. Their
antileishmanial properties are mediated through inhibition of trypanothione synthetase
and inhibition of topoisomerase activity and apoptosis induction in L. donovani
(Chowdhury et al., 2011; Saudagar and Dubey, 2014). Additionally, betulin derivatives
were reported to impair the viability and host–parasite interaction of Leishmania
braziliensis without being cytotoxic to the macrophages (Alcazar et al., 2014). Betulin
and its derivatives have been widely studied for their anticancer properties and can also
emerge as new antileishmanial drugs due to their selective toxicity toward the parasite
cells.

Table (3.13). Antileishmanial activity of C. canescens extracts.

Name
Dichloromethane extract
Ethanol extract

Promastigotes

Macrophage

Index

Amastigotes

Index

L. amazonensis

BALB/c
Mouse

(CC50/CI50pro)

L. amazonensis

(CC50/CI50ama)

< 12.5

63.7 ± 5.0

>5

20.5 ± 5.0

3

33.6 ± 5.9

202.8 ± 6.8

6

30.6 ± 3.9

7

IC50; Concentration of extract that caused 50 % of growth inhibition.
CC50; Concentration of extract that caused 50 % of mortality.
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3.7 Allelopathic effects
The term allelopathy describes the chemical interactions between plants where one plant
interferes with the germination and growth of another plant. Allelopathic compounds are
thought to enter the surrounding environment via volatilization, leaching with rain, and
decomposition of plant litter, thereby inhibiting the growth of competitors or species that
may threaten the plant’s survival. In this manner, the plant may have an ecological role in
its ecosystem by affecting plant spacing, succession, and community composition
(Fischer et al., 1994). The allelopathic activity of the isolated compounds was evaluated
on the germination and growth of Lactuca sativa (lettuce) and Lolium perenne (perennial
ryegrass). Almost all the tested compounds, except betulin and n-tetracosane, showed
significant germination inhibition of both L. sativa and L. perenne (Table 3.15) in a
concentration-dependent manner. The IC50 values for germination inhibition are shown in
Table (3.16). L. perenne seeds were less susceptible to germination inhibition than L.
sativa. Ursolic acid showed the highest germination inhibition of L. sativa (IC50 = 90.91
µg/mL) while the highest germination inhibition of L. perenne was due to its isomer,
oleanolic acid (IC50 = 309.43 µg/mL). The allelopathic properties of ursolic acid and
oleanolic acid have already been described (Rizvi, 2012; Szakiel et al., 2003). The six
compounds did not affect the shoot and root growth of L. perenne much. Ursolic acid
showed activity on radicle and shoot growth of L. perenne at a concentration of 1000
µg/mL and higher.
In natural ecosystem, allelopathy is a complicated process that involves many factors, and
terpenoids might act synergistically. C. canescens is thought to play a significant
ecological role in maintaining a healthy scrub ecosystem by inhibiting the germination of
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native grasses (De la Peña, 1985). Fischer et al. (1994) suggested that by inhibiting
germination of the grasses, the development of the more fire-prone sandhill ecosystem is
prevented, and the scrub ecosystem is maintained. The presence of significant quantities
of ursolic acid suggests that this compound might contribute to the strong allelopathic
effect of C. canescens. Ursolic acid is thought to act as a natural detergent by leading
water-insoluble monoterpenes to form micelles, rendering them water-soluble, thereby
enhancing their ability to leach into rainwater for delivery into the soil (De la Peña, 1985;
Rizvi, 2012). Weidenhamer et al. (1993) reported that ursolic acid helps to co-solubilize
the allelopathic monoterpenes in water to be more effective.
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Table (3.15). Allelopathic activity of isolated compounds on lettuce (Lactuca sativa) and perennial
ryegrass (Lolium perenne).
Compound

Concentration
(µg/mL)

β-amyrin

4000
2000
1000
500
250
125
4000
2000
1000
500
250
125
4000
2000
1000
500
250
125
4000
2000
1000
500
250
4000
2000
1000
500
250
125
4000
2000
1000
500
250
125
62.5

Betulin

Myrtenic acid

n-Tetracosane

Oleanolic acid

Ursolic acid

Germination Inhibition (%)
Lactuca
Lolium
sativa
perenne
100
100
100
100
100
100
93.33
60
70
40
36.67
100
73.33
100
73.33
86.67
43.33
73.33
36.67
56.67
30
23.33
100
100
100
100
100
100
80
66.67
70
46.67
33.33
23.33
100
53.33
100
46.67
76.67
36.67
63.33
33.33
40
30
100
100
100
100
96.67
83.33
83.33
73.33
66.67
43.33
40
33.33
100
100
100
100
100
70
100
40
70
36.67
60
3.33
36.67
-

Seedling growth (% of controls)
Lactuca sativa
Lolium perenne
radicle
hypocotyl radicle hypocotyl
53.89a
44.96a
27.46a
60.88a
50.05a
23.38a
75.64b
21.08a
69.71c
99.36c
110.90c
a
d
62.87
127.23
116.31c
b
c
69.61
110.54
99.26c
b
c
70.47
83.73
76.29b
85.13c
64.37b
49.62a
38.02a
89.82c
68.65b
39.29a
83.53c
53.41a
51.58a
a
44.04
17.74a
c
88.82
75.42c
73.14b
76.57c
55.24a
c
a
92.27
69.85
39.29a
b
c
75.85
99.79
70.98b
89.82b
47.21a
60.84b
80.83c
74.07b
80.49c
c
a
107.78
62.62
52.79a
c
a
101.30
65.51
67.18b
36.93a
30.42a
84.30c
77.74c
b
c
70.86
87.47
75.78c
b
b
74.85
76.25
73.95b
82.73b
-

Significance vs. controls: a P < 0.001, b 0.01< P < 0.1, c 0.1 < P < 0.5, d not significant.
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Table (3.16). IC50 values for the allelopathic activity of isolated compounds.
Compound
β-amyrin
Betulin
Myrtenic acid
n-Tetracosane
Oleanolic acid
Ursolic acid

IC50 (µg/mL)
Lactuca sativa
Lolium perenne
167.82
353.55
206.61
1237.73
172.35
314.98
343.76
2828.43
167.36
309.43
90.91
652.76
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IC50 (µM)
Lactuca sativa
Lolium perenne
393.28
828.53
466.68
2795.71
1036.89
1894.97
1015.05
8351.84
366.46
677.53
199.05
1429.27

CHAPTER FOUR

Conclusions and Future Work
4.1 Findings
Conradina canescens (Lamiaceae) is an endemic evergreen shrub native to Florida,
Mississippi and Alabama, with no phytochemical or biological studies registered in the
literature. Thus, a phytochemical study and a toxicity analysis were performed for the
first time. In this investigation, the screening and identification of compounds was driven
by looking for bioactive compounds. The essential oil of C. canescens was analyzed by
GC-MS and found to be rich in monoterpenoids, particularly 1,8-cineole, myrtenal, pcymene, camphor, myrtenol, myrtenyl acetate, and α-pinene. C. canescens essential oil
was screened for antimicrobial activity and cytotoxic activity but was found to be
inactive. The oil showed remarkable germination inhibition of both L. sativa and L.
perenne. Because its oil chemical composition is comparable to that of rosemary, C.
canescens may be a useful and beneficial herb.
A total of six compounds, namely ursolic acid (62.40%), betulin (8.41%), β-amyrin
(4.60%), myrtenic acid (2.88%), n-tetracosane (1.44%), and oleanolic acid (1.05%) were
isolated. The structures of the isolated compounds were established by spectroscopic
studies using NMR and IR spectroscopy. The crude extract and isolated compounds were
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screened for antimicrobial, antileishmanial and cytotoxic activity. The crude extract
showed substantial cytotoxic, antimicrobial and antileishmanial activities. Ursolic acid
and betulin showed significant cytotoxic effects against breast cancer (MCF-7 and MDAMB-231) and bladder cancer (5637) cell lines emphasizing a medicinal importance of the
plant. n-Tetracosane exhibited the most antibacterial activity while myrtenic acid showed
the highest antifungal activity. C. canescens chloroform extract, β-Amyrin, n-tetracosane,
ursolic acid and oleanolic acid demonstrated moderate activities on A. salina nauplii.
Almost all the tested compounds, except betulin and n-tetracosane, showed significant
germination inhibition of both L. sativa and L. perenne in a concentration-dependent
manner, with ursolic acid being the most active. The results of the current study
emphasize a potential medicinal and economic importance of C. canescens.

4.2 Future Work
In recent years, the understanding of intracellular pathways in cancer cells has increased
rapidly, contributing to the development of drugs with more specific targets, such as
growth factors, signaling molecules, cell-cycle proteins, modulators of apoptosis, and
molecules that promote angiogenesis. Studies on the anticancer effect of pentacyclic
triperpenoids have demonstrated that almost all pentacyclic triterpenoids induce
apoptosis and inhibit growth of cancer cells derived from solid and non-solid tumors
(Safe et al., 2012). Several triterpenoids decrease the expression of specificity protein
(Sp) transcription factors and several pro-oncogenic Sp-regulated genes in multiple
cancer cell lines. The mechanisms of this response are both compound- and cell contextdependent and include activation of both proteasome-dependent and -independent
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pathways. Triterpenoid-mediated induction of reactive oxygen species (ROS) has been
characterized as an important proteasome-independent pathway for downregulation of Sp
transcription factors. Triterpenoids also activate or deactive nuclear receptors and Gprotein coupled receptors, and these pathways contribute to their antitumorigenic activity
and may also play a role in targeting Sp1, Sp3 and Sp4 which are highly overexpressed in
multiple cancers and appear to be important for maintaining the cancer phenotype (Safe
et al., 2012). One of the ways this work could be continued is to investigate the
mechanism of action of the cytotoxic triterpenes, betulin and ursolic acid, isolated from
C. canescens, by assaying for inhibition of DNA polymerases and DNA topoisomerases,
for interaction with growth factor signaling systems, and for disruption of microtubulerelated cell functions.
Molecular docking is a field of in-silico molecular modeling method that is used to
predict the preferred orientation of a small organic molecule with biological
macromolecules (usually proteins). Molecular docking studies can be carried out on
potential protein targets such as the DNA-binding and cleavage domain of human
topoisomerase II and the ATPase region of topoisomerase II using the Molegro Virtual
Docker. This will show the interactions between the compound and target protein that
gives the compound its inhibitory activity.
Separation of the methanol extract will be carried out using “reverse phase” flash
chromatography on Sephadex LH-20. Fractions of 10 mL each will be collected and
checked by HPLC. Fractions having comparable HPLC’s will be combined then screened
for cytotoxic activity using the MTT assay. The actual steps in the fractionation scheme
will be adjusted as needed to isolate different classes of active compounds. Analysis of
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the active fractions will be carried out by HPLC-UV to determine the number and type of
compounds present. This small scale chromatographic separation will further fractionate
the extract until a pure compound is reached.
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